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Abstract 
The authors collaborated with a team of clinicians at a skilled nursing facility (SNF) in Gig 
Harbor, WA to identify the need for measures of UE functional use that are most appropriate to utilize 
with the two largest client populations at their facility, stroke and Parkinson’s disease (PD). In order to 
meet the clinical utility characteristics identified as important by the clinicians, the authors searched two 
databases that contain overviews of assessments. This search identified five stroke assessments and two 
PD assessments that met the clinical utility parameters outlined by the clinicians. The authors then 
conducted a systematic literature search to identify any relevant studies pertaining to each assessment. 
These studies were reviewed and the results presented in the form of a critical appraisal of the topic 
(CAT) that included the purpose, measure, population, psychometric characteristics, results and 
limitations of the studies. The initial search for articles yielded 869 articles, 33 of which met the inclusion 
criteria. The authors recommend use of the Chedoke Arm and Hand Activity Inventory-9 assessment with 
clients post-stroke due to its robust evidence and wide variety of levels of impairments post-stroke 
included in the studies, and use of the Muscle Disorder Society’s Unified Parkinson’s Disease Rating 
Scale assessment with clients with PD due to its inclusion of functional tasks and higher volume of 
research. 
The knowledge translation implementation phase of the project involved an in-service (interactive 
demonstration and scoring) and two brochures outlining the findings related to each assessment. A 
follow-up survey measured the effectiveness of the in-service and the value of the research to clinicians’ 
occupational therapy practice at their clinic. The survey results indicated that the clinicians found the 
research helpful and the knowledge translation process efficient. In addition, they indicated that it is likely 
that they will implement the CAHAI and the MDS-UPDRS assessments at their facility.  
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Executive Summary 
Occupational therapy clinicians at a skilled nursing rehabilitation clinic collaborated with Master 
of Science in Occupational Therapy students from the University of Puget Sound on a research project. 
The aim of the project was to answer a clinical question and streamline the knowledge translation process. 
The project was completed over a period of approximately 9 months and it was broken down into the 
following two parts: 1) a systematic review of the literature to recommend specific assessments, and 2) 
assisting the clinicians with implementing the recommendations. The researchers began by interviewing 
the clinicians to learn about their needs and interests. Their question was: Which assessment is the most 
accurate and sensitive outcome measure of voluntary motor control in the upper extremity (UE) that can 
be used in their setting? The question was multifaceted and included applicability to the primary 
diagnoses seen in the facility, psychometric data properties to support its use in this setting, focus on 
functional use of the UE versus impairment, and feasibility and practicality to administer widely within 
the preexisting framework in the facility.  
The outcome measure used by occupational therapists at the facility was the Modified Barthel 
Index. The occupational therapists were dissatisfied as they felt that this measure did not identify changes 
in UE function, an area that they spent significant time addressing in treatment. To be clinically useful, 
the clinicians identified the clinical utility parameters of the measurement tool (e.g., under $300 and <30 
minutes to administer and score) as being important factors to consider in the selection of the assessment, 
as well as its suitability for persons with stroke or Parkinson’s disease, the two largest client populations 
seen by the facility. The systematic literature review was completed in two stages: identifying 
assessments for consideration that met the clinical utility parameters, and investigating the psychometric 
properties of the identified assessments. Two databases of assessments were searched to find measures of 
UE function, which were then narrowed down by the clinical utility factors outlined by the clinicians. In 
total, five assessments for patients with stroke and two assessments for patients with Parkinson’s disease 
were included in the search for articles. Thirty-three articles from ten databases were included in the 
critical appraisal of the topic (CAT) to allow the authors to analyze and compare the psychometric 
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properties of each assessment. Some limitations that negatively affected the generalizability of the 
studies’ findings included excluding participants based on their cognitive impairment, level of motor 
return, and severity of condition symptoms.  
The researchers concluded that the Chedoke Arm and Hand Activity Inventory (CAHAI-9) and 
the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) are both 
measures that have strong psychometric properties including demonstrated high validity, reliability, and 
sensitivity for measuring upper extremity functional use in patients with mild to severe impairments as a 
result of stroke or PD, respectively. The two assessments also meet the specific needs of the clinicians in 
terms of cost, time to administer, and ability to measure functional use of the upper extremity. 
The next phase of the project was to identify methods to support the implementation of the 
findings of the CAT (i.e., utilization of the two assessments) by the collaborating clinicians. An in-service 
was provided to the clinicians with the aims of familiarizing them with the assessments and providing 
them with an opportunity to have their concerns addressed. The in-service included a demonstration of 
how to administer the CAHAI-9 and an opportunity to practice scoring it. The authors left the clinicians 
with a CAHAI-9 manual, a cost estimate for creating a CAHAI-9 test kit, and two brochures that each 
included an overview of the CAHAI-9 and the MDS-UPDRS. During the in-service, the clinicians 
identified possible concerns, such as how cognitive impairments would affect performance, and how the 
assessment might be used with Medicare G-codes. At the conclusion of the in-service, the rehabilitation 
director told the other clinicians that she would like to set up a meeting with them soon to discuss the 
CAHAI-9 further and take the next steps necessary to implement the use of the assessment in their clinic.  
A follow-up survey was used to further measure the outcome of the knowledge translation 
process. The clinicians indicated on the survey that it is likely that they will implement the CAHAI and 
the MDS-UPDRS assessments at their facility. When asked, they gave no suggestions for ways to 
improve the process of knowledge translation. They indicated that the research was useful to them and the 
knowledge translation process was efficient. 
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FOCUS QUESTION 
Which of the selected assessments is the most accurate and sensitive outcome measure of 
functional abilities of the upper extremity for a skilled nursing-based rehabilitation setting? This question 
has multiple other facets included under it: is this tool applicable to the primary diagnoses seen in the 
facility (stroke and Parkinson’s disease), does the measure have psychometric properties to support its use 
in this setting, and is it feasible and practical to administer widely within the preexisting framework in the 
facility? 
CLINICAL SCENARIO 
A director of rehabilitation and her team at a skilled nursing facility rehabilitation clinic is 
wondering which upper extremity functional use/ability measure for clients with neurological upper 
extremity impairment is the most accurate and sensitive. Approximately 35% of the clients treated at the 
facility have been diagnosed as either post-stroke (15%) or as having Parkinson’s disease (20%).  It is 
important to note that the clinicians only treat PD secondary to other diagnoses such as falls.  The 
clinicians want a tool that is sensitive enough to measure changes in upper extremity voluntary motor 
control during functional use for clients who are post-stroke and for clients with Parkinson’s disease, both 
at intake and throughout the intervention process.  They are displeased with their current outcome 
measure, the Modified Barthel Index, because it does not identify changes in upper extremity 
performance and does not meet their needs.  The clinicians identified that the clinical utility of the 
assessment (e.g., under $300 and <30 minutes to administer and score, and ability to measure motor 
control in the context of function) as an important factor to consider in the selection of the assessment. 
Because such a large portion of the client population seen at the facility has a diagnosis of either stroke or 
PD, the authors analyzed and summarized research on both of those populations in this critical appraisal 
of the topic (CAT). 
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REVIEW PROCESS 
Rationale for Stage 1, Identifying Assessments for Consideration 
The authors first narrowed the search by assessment type to provide a more focused 
understanding of assessments pertinent to upper extremity motor control in patients who are post-stroke 
or have PD. The authors conducted searches of the two diagnoses separately.  
Search Strategy for Stroke Assessments. A number of assessments measure upper extremity 
ability or functional use in individuals with stroke. However, it was important to offer the clinicians a 
manageable sample of assessments to compare and from which they might select the one that best suits 
their needs. Stroke Engine and Rehab Measures are two trusted databases designed to bridge the gap 
between research and clinical practice (Korner-Bitensky & Rochette, n.d.; Rehabilitation Measures 
Database, n.d.). Health professionals often use these sites to choose appropriate assessments and 
interventions, many of which have been researched specifically with individuals who are post-stroke. 
Additionally, the two databases explicitly list clinical utility features so assessments that met the needs of 
the clinicians could be identified prior to searching for studies that evaluate the psychometric features of 
the measures.  
An initial search of the Rehab Measures database produced 27 potential assessments for inclusion 
and a search of the Stroke Engine database produced 13. There were 8 assessments that were common to 
both databases. As a result, there were a total of 32 distinct assessments of motor control for people post-
stroke that were identified for consideration. Assessments were further narrowed down by applying 
specific exclusion criteria (based on the clinicians’ stated needs for clinical utility and the information 
available related to the psychometric characteristics of the measure) to ensure that each assessment 
included in the literature review (Stage 2) would meet the clinicians’ needs.   
Exclusion Criteria: 
• < 2 articles on psychometric data of assessment 
• Insufficient information available (e.g., no cost information available) 
• > 30 minutes to administer and score 
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• > $300 
• Assessments that measure client factor level impairments only 
• Client-reported outcome measures 
• > 50% of task items included gait/mobility 
• Assessments appropriate for a pediatric population only 
•  
•  
•  
•  
 
 
 
 
 
 
 
 
 
Figure 1: Flow chart of the process of identifying assessments for stroke to include in this critical 
appraisal. 
Search Strategy for PD assessments. There are a limited number of assessments that measure 
upper extremity motor control in individuals with PD identified by our initial searches. A database 
comparable to Stroke Engine that lists information about assessments for individuals with PD was not 
found. A search of Rehab Measures yielded eight assessments appropriate for use with individuals who 
have PD. The authors expanded the search for assessments that are appropriate for use with individuals 
with PD by searching for systematic reviews (see Stage 2). In addition, 7 other assessments that focus on 
upper extremity motor control were selected from a recent systematic review (Proud et al., 2015). The 
systematic review was found in PubMed using the following search string: “upper extremity” AND 
“Parkinson” AND “systematic review”. The systematic review by Proud et al. (2015) was selected 
because it was published within one year of writing this CAT and its authors compared assessments that 
UE Assessments identified 
through Stroke Engine (n=27) 
and Rehab Measures (n=13) 
 
Assessments once duplicates 
removed (n=32) 
Assessments excluded (n=27) 
Client self-report: 10 
Measured dexterity: 3 
Too long to administer: 4 
Too costly: 2 
Different population: 4 
Multiple exclusion criteria: 4 UE motor control assessments 
appropriate for pts with stroke 
(n=5) 
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measure upper extremity functioning in patients with PD. Using the same strategy as used for stroke, PD 
assessments were also narrowed down by applying specific exclusion criteria to ensure that each 
assessment included in the article search (Part 2) would meet the clinicians’ needs.  
Exclusion Criteria: 
• < 2 articles on psychometric data of assessment 
• Insufficient information available (e.g., no cost information available) 
• Replaced by a psychometrically superior version 
• > 30 minutes to administer and score 
• > $300 
• Assessments that measure dyskinesia or tremor only  
• Client-reported outcome measures 
• Primary utility is in pharmaceutical research 
• Assessments appropriate for a pediatric population only 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Flow chart of the process of identifying assessments for PD to include in this critical appraisal. 
UE Assessments identified 
through Rehab Measures 
(n=8) and Proud et al. 
article (n=7) 
Assessments excluded (n=12) 
 
Client self-report: 2 
Too long to administer: 2 
Outdated: 1  
Too new: 1 
Outside of OT scope: 1 
PD sub-population: 2 
Measures only dyskinesia/tremor: 5 
UE motor control 
assessments appropriate for 
patients with PD (n=2) 
Assessments once 
duplicates removed (n=14) 
 
Duplicates: (n=1) Movement Disorder 
Society’s Unified Parkinson’s Disease 
Rating Scale 
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Results of Stage 1 search strategy: 
One assessment from Stroke Engine and four assessments from Rehab Measures that measure 
upper extremity motor control in patients post-stroke met the inclusion and exclusion criteria.  
The following five assessments that measure upper extremity motor control in patients who are post-
stroke met the inclusion and exclusion criteria: 
1.      Action Research Arm Test (ARAT) 
2.      Streamlined Wolf Motor Function Test (S-WMFT) 
3.      The Chedoke Arm and Hand Activity Inventory (CAHAI) 
4.      Arm Motor Abilities Test (AMAT) 
5.      Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) 
Only one assessment from the Proud et al. (2015) article met the search criteria and was deemed 
appropriate for the collaborating clinicians to administer to patients with PD. Searching Rehab Measures 
for assessments for patients with PD that met all of the inclusion and exclusion criteria uncovered only 
one assessment. The following two assessments that measure upper extremity motor control in patients 
with PD met the inclusion and exclusion criteria: 
1.      Rush Dyskinesia Rating Scale (RDRS) 
2.      Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) 
Following Stage 1, the assessment search, the first research question was answered. Seven assessments 
that were applicable to the primary diagnoses seen in the facility and met the clinical utility needs 
identified by the clinicians were identified. 
Rationale for Stage 2, Investigating the Psychometric Properties of Select Assessments 
Occupational therapists and other health care professionals are expected to provide care guided 
by best practices to which knowledge translation is closely tied. This critical appraisal of the topic was 
initiated in an attempt to facilitate knowledge translation. The process of knowledge translation attempts 
to eliminate the underutilization of evidence-based research to support systems of healthcare (Center on 
Knowledge Translation for Disability and Rehabilitation Research [KTDRR], 2005). Knowledge 
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translation involves ethically applying research to change and improve the quality and effectiveness of 
care that patients receive. The selection of an assessment based on diagnosis and clinical utility alone is 
insufficient to implement an assessment into practice. It is important to consider how different 
assessments may be more or less appropriate for particular client populations. For example, the sensitivity 
of some assessments may differ depending on the severity of a person’s health complications. This CAT 
provided a more in-depth analysis of the psychometric properties of each assessment as they were 
administered to specific populations.  
Search Strategy for Stroke Articles.  Databases were chosen based on their relevance to the 
field of occupational therapy with the expectation that they would return many results. Key terms were 
chosen based on the assessments included and what information was relevant to the needs of the 
collaborating clinicians (see Table 1). When necessary, filters were added to the search in order to narrow 
down results to garner more relevant articles that fit the inclusion criteria (See Table 3). 
Stroke Related Articles Search Process 
Table 1 
Search Terms for Stroke-Related Studies 
Key Terms Synonyms Alternate Spellings 
Action Research Arm Test  ARAT 
Arm Motor Abilities Test Arm Mobility Arm Test AMAT 
The Chedoke Arm and Hand Activity Inventory  CAHAI, Chedoke 
Motor Evaluation Scale for Upper Extremity in 
Stroke Patients 
 MESUPES 
Psychometric Clinimetric, reliable, valid, 
sensitivity, specificity 
reliab*, valid* 
Streamlined Wolf Motor Function Test  S-WMFT, SWMFT 
Upper Extremity Arm, hand, upper limb, UE 
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Table 2 
Databases Searched for Stroke-Related Studies 
Databases and Sites Searched for Stroke 
AJOT PEDro 
BJOT PubMed 
CINAHL ScienceDirect 
CJOT www.rehabmeasures.com 
OTSeeker www.strokengine.ca 
 
Table 3 
Stroke-Related Studies Search Strategy and Results 
Search key Filters Database Hits Date 
Action Research Arm Test Exact phrase AJOT 13 10/26/2015 
Action Research Arm Test OR 
ARAT 
1995-present BJOT 8 2/06/2016 
(“Action Research Arm Test” 
OR ARAT) AND 
(psychometric OR reliab* OR 
valid* OR specificity OR 
sensitivity OR rasch) 
Full-text, abstract available, 1995-
2015, English 
CINAHL 16 10/24/2015 
Action Research Arm Test OR 
ARAT 
 CJOT 0 2/2/16 
Action Research Arm Test OR 
ARAT 
 OT Seeker 0 10/26/2015 
Action Research Arm Test  PEDro 97 10/24/2015 
(("Action Research Arm Test" 
OR ARAT)) AND 
(psychometric OR reliabil* OR 
valid* OR specificity OR 
sensitivity OR rasch) 
English, 1995-2015, full-text PubMed 116 10/24/2015 
“Action Research Arm Test” 
AND (psychometric OR 
reliab* OR valid* OR 
Journal or review article, 1995-
present, full-text 
ScienceDirect 136 10/24/2015 
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clinimetric OR specificity OR 
sensitivity OR rasch) 
Arm Motor Ability Test OR 
AMAT OR Arm Mobility Arm 
Test 
1995-present, assessment 
development and testing, adult, 
AJOT 1 1/16/2016 
Arm Motor Ability Test OR 
AMAT OR Arm Mobility Arm 
Test 
 BJOT 1 2/06/2016 
(Arm Motor Ability Test OR 
Arm Mobility Arm Test OR 
AMAT) AND (psychometric* 
OR valid* OR reliab* OR 
sensitivity OR specificity OR 
clinimetric* OR Rasch) 
 CINAHL 9 10/25/2015 
Arm Motor Ability Test OR 
AMAT 
 CJOT 0 2/2/16 
Arm Motor Ability Test OR 
AMAT OR Arm Mobility Arm 
Test 
 OTSeeker 0 1/16/2016 
Arm Mobility Arm Test  PEDro 31 10/25/2015 
AMAT  PEDro 10 1/16/2016 
Arm Motor Ability Test  PEDro 52 2/19/2016 
(Arm Motor Ability Test OR 
Arm Mobility Arm Test OR 
AMAT) AND (psychometric* 
OR valid* OR reliab* OR 
sensitivity OR specificity OR 
clinimetric* OR Rasch) 
Free full text, 1995-present, 
Humans, Clinical Trial, 
Comparative Study, Introductory 
Journal Article, Journal Article, 
Randomized Controlled Trial, 
Review, Systematic Reviews, 
Validation Studies, English, 
PubMed 47 2/22/2016 
(Arm Motor Ability Test) OR 
(Arm Mobility Arm Test) OR 
(AMAT) AND (psychometric* 
OR valid* OR reliab* OR 
sensitivity OR specificity OR 
clinimetric* OR Rasch) 
1995-present, title/abstract/key 
terms 
Science 
Direct 
41 1/16/2016 
“The Chedoke Arm and Hand 
Activity Inventory” 
 AJOT 5 10/24/2015 
“The Chedoke Arm and Hand 
Activity Inventory” 
 BJOT 0 2/06/16 
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“The Chedoke Arm and Hand 
Activity Inventory” 
 CINAHL 19 10/24/2015 
“The Chedoke Arm and Hand 
Activity Inventory” 
 CJOT 0 2/2/16 
“The Chedoke Arm and Hand 
Activity Inventory” 
 OT Seeker 0 10/24/2015 
“The Chedoke Arm and Hand 
Activity Inventory” 
 PEDro 0 10/24/2015 
“The Chedoke Arm and Hand 
Activity Inventory” 
 PubMed 22 10/24/2015 
“The Chedoke Arm and Hand 
Activity Inventory” 
 Science 
Direct 
48 10/24/2015 
Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients 
Research article, hand and upper 
extremity, and 1995-present 
AJOT 14 11/13/2015 
Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients OR MESUPES 
 BJOT 0 2/06/2016 
(Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients OR MESUPES) AND 
(psychometric* OR valid* OR 
reliab* OR sensitivity OR 
specificity OR clinimetric* OR 
Rasch) 
1995-present CINAHL 2 11/10/2015 
Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients OR MESUPES 
 CJOT 0 2/06/2016 
Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients 
 OT Seeker 0 11/13/2015 
Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients 
 PEDro 8 2/06/2016 
("Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients" OR "MESUPES") 
AND (psychometric* OR 
valid* OR reliab* OR 
Comparative studies, journal 
articles, meta-analyses, reviews, 
systematic reviews, validation 
studies, full-text, 1995-present, 
humans 
PubMed 65 11/13/2015 
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sensitivity OR specificity OR 
clinimetric* OR Rasch) 
(Motor Evaluation Scale for 
Upper Extremity in Stroke 
Patients OR MESUPES) AND 
(psychometric* OR valid* OR 
reliab* OR sensitivity OR 
specificity OR clinimetric* OR 
Rasch) 
Abstract/title/key terms, journals, 
1995-present 
ScienceDirect 3 11/13/2015 
“Streamlined Wolf Motor 
Test” OR S-WMFT 
 AJOT 0 11/12/2015 
“Streamlined Wolf Motor 
Test” OR S-WMFT 
 BJOT 0 2/06/2016 
(“Streamlined Wolf Motor 
Function Test” OR S-WMFT) 
AND (reliab* OR valid* OR 
psychometric OR specificity 
OR sensitivity OR rasch) 
 CINAHL 6 11/12/2015 
“Streamlined Wolf Motor 
Test” OR S-WMFT 
 CJOT 0 2/2/16 
“Streamlined Wolf Motor 
Test” OR S-WMFT 
 OT Seeker 2 11/12/2015 
“Streamlined Wolf Motor 
Test” OR S-WMFT 
 PEDro 0 11/12/2015 
(“Streamlined Wolf Motor 
Function Test” OR S-WMFT) 
AND (reliab* OR valid* OR 
psychometric OR specificity 
OR sensitivity OR rasch) 
 PubMed 5 11/12/2015 
(“Streamlined Wolf Motor 
Function Test” OR S-WMFT) 
AND (reliab* OR valid* OR 
psychometric OR specificity 
OR sensitivity OR rasch) 
In journals, 1995-present, articles 
or review articles 
ScienceDirect 92 11/12/2015 
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Inclusion/ Exclusion of Stroke articles.   
Inclusion criteria for stroke articles: 
• Addressed upper extremity motor control 
• Contained psychometric data 
• Published within the past 20 years 
Exclusion criteria for stroke articles: 
• Did not address target population 
• Focused on an intervention 
• Published in a language other than English 
• Not accessible to the researchers through either the University of Puget Sound or University of 
Washington school databases or inter-library loan systems 
• Addressed an alternate version of the assessment published at an earlier date 
After analysis of the articles following the exclusion criteria, it was decided that articles that 
compare the assessment to one or more assessments not within this scope of study would be excluded as 
well. By adding this additional exclusion criteria, it was ensured that all the articles contained only 
relevant information regarding the assessments chosen. 
Action Research Arm Test (ARAT).  Searching the databases listed above resulted in 386 
articles. Of those articles, 371 were excluded: 276 focused on interventions, seven were not in English, 59 
analyzed different assessments, 10 were duplicates from other databases, six targeted a different 
population, three were not available in full text, one contained no psychometric data and nine compared 
the ARAT to assessments not of interest. A total of 15 articles regarding the ARAT were included in the 
CAT.  
Arm Motor Ability Test (AMAT).  Searching the databases listed above resulted in 192 articles. 
Of those articles, 187 were excluded: 167 focused on interventions, 15 analyzed different assessments, 
two were duplicates from other databases, one targeted a different population, one was unavailable in full 
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text and one compared the AMAT to an assessment not of interest. A total of five articles regarding the 
AMAT were included in the CAT.  
Chedoke Arm and Hand Activity Inventory (CAHAI).  Searching the databases listed above 
resulted in 94 articles. Of those articles, 87 were excluded: four were duplicates from other databases, 
three were unavailable in full text, and 80 were not relevant to the assessment. A total of seven articles 
regarding the CAHAI were included in the CAT. 
Motor Evaluation Scale for Upper Extremity in Stroke Patients 
(MESUPES).  Searching the databases listed above resulted in 92 articles. Of those articles, 90 
were excluded: 35 focused on interventions, 52 analyzed different assessments, two were duplicates 
from other databases, and 1 targeted a different population. A total of two articles regarding the 
MESUPES were included in the CAT. 
Streamlined Wolf Motor Function Test (S-WMFT).  Searching the databases listed above 
resulted in 105 articles. Of those articles, 101 were excluded: 77 focused on interventions, six were not in 
English, four analyzed other assessments, six were duplicates from other databases, three contained no 
psychometric data, one compared the S-WMFT to an assessment not of interest, and four were a different 
version of the assessment. A total of four articles regarding the S-WMFT were included in the CAT. 
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Figure 2: Flow chart of the identification of studies on stroke assessments for inclusion in this critical 
appraisal 
Search Strategy for PD articles. A search using the exact search string "parkinson" AND "upper 
extremity" AND "assessment" through PubMed returned a recent systematic review of upper extremity 
measures specifically for patients with Parkinson’s disease done by Proud et al. (2015). Articles from 
inception to November 2013 were included in that review. Repeating the search strategy and applying a 
date filter of November 2013 to February 2016, no other articles were found. Proud et al.’s (2015) 
systematic review was utilized because the purpose of their review was to discover measurement tools 
used for upper limb evaluation in people with PD. Because the Rush Dyskinesia Rating Scale was added 
to the list of recommended PD assessments after searching Rehab Measures, a search of databases for the 
assessment was conducted (See Table 6).  
  
Selected stroke related articles for 
this review (n = 33) 
Systematic literature search (n =869) 
AJOT: 33 
BJOT: 9 
CINAHL: 52 
CJOT: 0 
OTSeeker: 2 
Pedro: 198 
PubMed: 255 
Science Direct: 320 
Excluded (n = 836)  
Focus on intervention: 555 
Non-English language: 13 
Different assessment:  130 
Duplicates across databases: 24 
Different population: 8 
No full text available: 7 
No psychometric data: 4 
Compared to assessment not of 
interest: 11 
Discussed a different version of 
the assessment: 4 
Not relevant to the assessment: 80 
Potentially relevant articles (n =44) 
Excluded (n =11) 
Compared assessments 
not focused on in this 
study. 
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Parkinson’s Disease Related Articles Search Process 
Table 4 
Search Terms for Parkinson’s Disease-Related Studies 
Key Terms Synonyms Alternate Spellings 
Parkinson’s Disease  Parkinson*, PD 
Psychometric clinimetric, reliable, valid, sensitivity, specificity reliab*, valid* 
Rush Dyskinesia Rating Scale   
Upper Extremity Arm, hand, upper limb, UE 
 
Table 5 
Databases Searched for Parkinson’s Disease-Related Studies 
Databases and Sites Searched for Parkinson’s Disease 
AJOT PEDro 
BJOT PsychINFO 
CINAHL PubMed 
CJOT ScienceDirect 
Medline www.rehabmeasures.com 
OTSeeker  
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Table 6 
Parkinson’s Disease-Related Studies 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
 AJOT 0 1/16/2016 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
 BJOT 0 1/16/2016 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
1995-present, linked full 
text, academic journals 
CINAHL 0 1/16/2016 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
 CJOT 0 3/2/16 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
 OTSeeker 0 1/16/2016 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
 PEDro 0 1/16/2016 
Rush Dyskinesia Rating 
Scale 
Full text, 1995-present, 
Humans, Clinical Trial, 
Comparative Study, 
Introductory Journal 
PubMed 31 1/16/2016 
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Article, Journal Article, 
Randomized Controlled 
Trial, Review, Systematic 
Reviews, Validation 
Studies, 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
Full text, 1995-present, 
Humans, Clinical Trial, 
Comparative Study, 
Introductory Journal 
Article, Journal Article, 
Randomized Controlled 
Trial, Review, Systematic 
Reviews, Validation 
Studies, 
PubMed 10 1/16/2016 
(Rush Dyskinesia Rating 
Scale) AND 
(psychometric* OR valid* 
OR reliab* OR sensitivity 
OR specificity OR 
clinimetric* OR Rasch) 
1995-present, 
Abstract/Title/Keywords, 
Journals, 
ScienceDirect 1 1/16/2016 
(Parkinson OR 
“Parkinson* disease”) 
AND (“upper limb” OR 
“upper extremity” OR arm 
OR hand) AND 
(measure* OR assess* OR 
outcome OR tool OR 
instrument* OR dexterity 
OR disability OR ADL) 
English, research article, 
2013-present 
CINAHL 24 2/06/2016 
(Parkinson OR 
“Parkinson* disease”) 
AND (“upper limb” OR 
“upper extremity” OR arm 
OR hand) AND 
(measure* OR assess* OR 
outcome OR tool OR 
instrument* OR dexterity 
OR disability OR ADL) 
2013-present, linked full 
text, academic journals 
MEDLINE 32 2/06/2016 
Parkinson's Disease Upper 
Extremity Assessment 
 OTSeeker 0 2/06/2016 
(Parkinson's Disease OR 
PD) AND (upper 
extremity OR UE) AND 
(clinimetric* OR reliab* 
 OTSeeker 0 2/06/2016 
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OR valid* OR sensitivity 
OR specificity) 
Parkinson's Disease AND 
Upper Extremity AND 
Assessment 
 PEDro 0 2/06/2016 
(Parkinson OR 
“Parkinson* disease”) 
AND (“upper limb” OR 
“upper extremity” OR arm 
OR hand) AND 
(measure* OR assess* OR 
outcome OR tool OR 
instrument* OR dexterity 
OR disability OR ADL) 
2013-present, linked full 
text, academic journals 
PsychINFO 14 2/06/2016 
"parkinson" AND "upper 
extremity" AND 
"assessment" 
 PubMed 1 (PD 
systematic 
review) 
10/24/2015 
(Parkinson OR 
“Parkinson* disease”) 
AND (“upper limb” OR 
“upper extremity” OR arm 
OR hand) AND 
(measure* OR assess* OR 
outcome OR tool OR 
instrument* OR dexterity 
OR disability OR ADL) 
Full text, 2013-present, 
Humans, Clinical Trial, 
Comparative Study, 
Introductory Journal 
Article, Journal Article, 
Randomized Controlled 
Trial, Review, Systematic 
Reviews, Validation 
Studies, 
PubMed 36 2/06/2016 
 
Inclusion/ Exclusion Criteria for PD articles.   
Inclusion criteria for articles in Proud et al. (2015) systematic review: 
• Participants were diagnosed with idiopathic PD 
• Evaluated upper limb impairments activity limitations, and/or participation restrictions 
• Assessments evaluated the effects of treatment or disease progression 
• Focused on a measurement method that is replicable within clinical practice 
Exclusion criteria for articles in Proud et al. systematic review: 
• Not published in English 
• Did not provide detailed information regarding the assessment or assessment protocol 
IDENTIFYING AND IMPLEMENTING ASSESSMENTS  21 
• Utilized lab based assessments, such as kinematic analysis 
• Contained obsolete commercially produced tools 
• Letters, editorial, literature reviews and conference abstracts 
Inclusion criteria for Rush Dyskinesia Rating Scale articles: 
• Addressed upper extremity functional outcomes 
• Contained psychometric data 
• Published within the past 20 years 
Exclusion criteria for Rush Dyskinesia Rating Scale articles: 
• Did not address our target population 
• Focused on an intervention 
• Published in a language other than English 
• Not accessible to the researchers through either the University of Puget Sound or University of 
Washington school databases or inter-library loan systems 
• Addressed an alternate version of the assessment published at an earlier date 
Rush Dyskinesia Rating Scale (RDRS).  Searching the databases listed above resulted in 42 articles. 
Of those, 40 articles were excluded: 11 focused on other assessments, 26 focused on interventions, one 
was not available in full-text, and two were duplicates from other databases. Two articles from this 
search, in addition to the systematic review by Proud et al. (2015), were included in the CAT. 
Other Assessments Appropriate for Patients with PD Search.  Repeating the search strategy of 
Proud et al. (2015) to find articles on assessments appropriate for use with patients with Parkinson’s 
disease was largely unsuccessful. Using six of the nine databases we had access to and following the 
authors’ search strategy, there were 106 hits. All 106 were excluded: 100 articles were excluded because 
they focused on interventions and neurology topics, three analyzed different assessments, one analyzed a 
non-standardized assessment, one did not include psychometric data, and one was a duplicate (the 
systematic review included in this research). 
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Figure 3: Flow chart of the identification of studies on Parkinson’s disease assessments for inclusion in 
this critical appraisal 
Systematic literature search 
(n = 149 ) 
AJOT: 0 
CINAHL: 24 
CJOT: 0 
Medline: 32 
OTSeeker: 0 
PEDro: 0  
PsychINFO: 14 
Pubmed: 78 
Sciencedirect: 1 
Excluded (n = 146)  
Different assessments: 14 
Focus on intervention: 126 
Analyzed non standardized 
assessment: 1 
Unavailable to researchers: 1 
No psychometric data: 1 
Duplicates across databases: 3 
Selected articles for this 
review (n = 3) 
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RESULTS 
Stroke Assessments 
 
The Action Research Arm Test Results 
Author, 
Year 
Study 
Objectives 
Study Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description Inclusion 
and Exclusion Criteria 
Interventions & 
Outcome Measures 
Summary of Results Study 
Limitations 
Chen, Lin, 
Wu, & Chen 
(2012) 
Validate the 
internal 
construct and 
predictive 
validity of the 
ARAT. 
Secondary study, 
association/ 
correlation;  
Pyramid level: 
D2,  
AOTA level: IV 
Pts with stroke drawn 
from ongoing research 
into two interventions; 
N = 191 Inclusion: 
first time stroke, 
Brunnstrom ≥ 2, 
MMSE > 21, MAS < 
2, no severe medical 
issues, no joint pain, 
no balance-related 
safety issues. Mean 
age 55.17 yrs, mean 
time since stroke 
17.19 mo.  
Rasch analysis for 
construct validity; 
post-tx score 
correlation between 
ARAT, WFMT, 
MAL, SIS for 
predictive validity; 
pts randomly 
assigned to receive 
BAT, CIMT, or 
control 
intervention. 
Predictive validity fair 
with the SIS-Physical (p 
= 0.45); moderate with 
MAL-AOU (p = 0.62), 
SIS - hand function (p = 
0.58), and WMFT-TIME 
(p = -0.66); good with the 
WMFT-FAS (p = 0.76). 
Construct validity was 
disordered; authors 
recommend moving from 
a 4-point to a 3-point 
scale (collapse scores 0 
and 1). 
Limited to 
stroke 
survivors 
(both chronic 
and sub-
acute), no 
cognitive 
limitations, 
motor control 
return present 
in affected 
limb. All 
participants 
only had mild 
to moderately 
impaired UE 
function with 
a mean time 
post stroke of 
17.19 mo.   
Hsieh, 
Hsueh, 
Chiang, & 
Lin (1998) 
Verify the 
inter-rater 
reliability and 
validity of the 
ARAT. 
Prospective 
association/ 
correlation; 
Pyramid level:  
D2, AOTA level: 
IV 
N = 50. Inclusion: 
stroke pts, consecutive 
hospital admissions 
with stroke and the 
ability to follow verbal 
commands; mean age 
ARAT 
administered by 3 
different therapists 
on 3 days to find 
inter-rater 
reliability; 
ICC of 0.98 (95% 
confidence interval 0.97-
0.99, F = 178.3, p < 
0.0001); ANOVA found 
systematic bias on 3 
subscales (grip, pinch, 
Older 
population, 
no pts with 
global 
aphasia, 
relatively low 
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65 yrs, mean time after 
stroke 55 days. 
concurrent validity 
found by 
comparison with 
the MI, MAS, and 
UEMMAC. 
grasp); correlation r = 
0.96 with the MAS, r = 
0.87 with the MI, and r = 
0.94 with UEMMAC. 
Results supported  
validity of the ARAT as a 
measure of UE function. 
sample size, 
inter-rater 
reliability 
established 
with only 3 
therapists. 
Hsieh, Wu, 
Lin, Chang, 
Chen, & Liu 
(2009) 
Investigate and 
compare 
responsiveness 
and validity of 
the ARAT, 
WMFT, and 
the FMA. 
Association/ 
correlation; 
Pyramid level:  
D2, AOTA level: 
IV; data pulled 
from RCT (E2, I) 
N = 57. Pts with 
chronic stroke 
recruited from 3 
medical centers. 
Inclusion: first time 
stroke > 6 mo past, 
Brunnstrom stage ≥ 3, 
MAS ≤ 2.5, MMSE ≥ 
24, no confounding 
medical conditions. 
Measurements taken 
pre- and post-tx; mean 
age 54.56 yrs, mean 
time since stroke 
12.98 mo. 
Subjects receiving 
CIMT, BAT or 
conventional 
therapy for three 
wks; outcome 
measures compared 
to FIM scores as 
external criterion; 
responsiveness 
tested with 
Wilcoxon matched 
pairs, SRM; 
validity found with 
Spearman 
correlation 
coefficient. 
Responsiveness of FMA 
higher than ARAT 
(difference in SRM = 
0.47) and WMFT-TIME 
(difference in SRM = 
1.04), but not WMFT-
FAS (difference in SRM 
= 0.12); construct 
validity: at pre-tx, ARAT 
had good correlation with 
other outcome measures 
(p = 0.63-0.77); at post-
tx, ARAT had moderate 
to good correlation (p = 
0.58-0.74); ARAT had 
low predictive validity 
with FIM scores. FMA 
has sound responsiveness 
and validity and is good 
for predicting a pts UE 
functioning post-tx. 
Authors recommend use 
of the FMA over ARAT 
or WMFT for assessing 
pts undergoing stoke 
rehab.  
Relatively 
low sample 
size, limited 
to mild to 
moderate 
chronic 
stroke with 
high 
cognition.  
Koh, Hsueh, Determine if Association/ N = 351. Recruited Study did not Unidimensionality Study limited 
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Wang, Sheu, 
Yu, Wang, 
& Hsieh 
(2006) 
ARAT is 
unidimensional
, and if test 
items can be 
made interval 
with Rasch 
analysis. 
correlation; 
Pyramid level:  
D2, AOTA level: 
IV 
from 5 in- and 
outpatient rehab 
departments, invited to 
participate if they had 
dx of stroke, ability to 
follow instructions, 
and absence of other 
major diseases or 
impairments. Median 
age 63 yrs, mean time 
since stroke 12.5 mo. 
include 
intervention; 
ARAT 
administered by 
same PT to all 
participants; 
Mokken analysis to 
determine 
dimensionality, 
Rasch analysis to 
determine if scores 
can be made 
interval. 
established: scalability 
coefficient of 19-item 
ARAT H = 0.95; one 
item (pinch ball bearing 
3rd finger and thumb) 
over Crit value 
benchmark of 80, when 
removed, scalability 
coefficient of 18-item 
ARAT H = 0.95, Pmatrix 
< 57, Restscore <15, 
indicating that items of 
18-item ARAT difficulty 
order is the same for all 
pts; only 4 items of the 
test (grasp ball, grasp 
block 5cm3, grasp block 
2.5 cm3, grip tube 1 cm3) 
fit Rasch analysis, thus 
the authors recommend 
that clinicians use the 19 
items of the ARAT as a 
whole, and not divide 
scores into the four 
subscales. 
to chronic 
stroke pts 
with no 
cognitive 
impairments 
and no 
comorbidities
. Sensory 
impairments 
were not 
addressed. 
Assessment 
administered 
by a PT. 
Lang, 
Edwards, 
Birkenmeier
, & 
Dromerick 
(2008) 
Estimate 
minimal 
clinically 
important 
difference in 
ARAT, 
WMFT, and 
MAL. 
Association/ 
correlation; 
Pyramid level:  
D2, AOTA level:  
IV; data pulled 
from pilot RCT 
(E2, I) 
N = 52.Pts from stroke 
research registries of 
VECTOR. Inclusion: 
stroke within 28 days, 
NIHSS motor arm 
items score 1-3, some 
voluntary UE motor 
return (ability to move 
jts against gravity), 
NIHSS consciousness 
Randomized into 1 
of 3 tx groups: 2 
hrs conventional tx, 
2 hrs shaping +  2 
hrs CIMT, 3 hrs 
shaping + 
constraint 90% 
waking hrs; pre- 
and post-testing 
done by blinded 
MCID if dominant hand 
affected for ARAT: 12 
raw value, 21 percent of 
total, 0.78 effect size. 
ARAT non-dominant 
hand: 17 raw score, 30 
percent of total, 1.10 
effect size. MCID scores 
of 16-30% were 
considered important to 
Limited to 
acute stroke;  
unable to find 
MCID in all 
instances; 
older 
population, 
intact 
cognition, in-
pt setting 
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score 0-1, SBMOC ≥ 
19, ability to follow 2-
step commands, no 
prior UE injury. 
Exclusion: no 
fluctuation in mental 
state, no UN, life 
expectancy > 1 yr. 
Mean age 64 ± 14 yrs, 
mean time since stroke 
9.5 ± 4.5 days. 
assessor; ARAT, 
WMFT, and MAL 
measured at start 
and after 14 days; 
MCID calculated 
for each measure 
using SPSS. Grip 
strength and 
composite UE 
strength also tested, 
but are not 
applicable to this 
study so results are 
not included. 
pts. Thus, the ARAT 
established a satisfactory 
level of MCID for the pts 
in this study. 
may not 
generalize to 
SNF.  
Lang, 
Wagner, 
Dromerick, 
& Edwards 
(2006) 
Examine 
responsiveness 
and validity of 
the ARAT in 
pts with acute 
stroke. 
Association/ 
correlation; 
Pyramid level:   
D2, AOTA level:  
IV, data pulled 
from pilot RCT 
(E2, I) 
N = 50, all subjects 
enrolled in VECTOR; 
NIHSS arm motor 
score 1-2, ability to 
move jts against 
gravity, ability to 
follow 2-step 
directions, no prior UE 
injury, (see above 
exclusion criteria). 
Mean age 63.7 ± 13.6 
yrs, mean time since 
stroke 9.5 ± 4.5 days. 
Randomized into 
groups described 
above; measures 
given by trained, 
blinded personnel 
at baseline, after 14 
days of tx, and at 
90 days for follow-
up; stroke severity 
measured with 
NIHSS, light touch 
with Semmes-
Weinstein 
monofilaments, 
pain with VAS, 
spasticity with 
MAS, FIM for 
disability measure 
(via phone).  
Responsiveness: single 
population effect size 
from day 0-14 = 1.018 
(large), from day 0-90 = 
1.390 (large); ARAT 
responsive to change 
during first wks and mo. 
following stroke. MCID 
is 10% (6 points on a 57-
point scale) indicating 
ARAT can detect 
smallest meaningful 
change.   
Construct validity (results 
given for day 0, day 14, 
and day 90): correlation 
with age p = -0.16, -0.44, 
-0.29 (moderately related 
at day 14); with stroke 
severity p = -0.15, -0.24, 
-0.29 (minimally related); 
Sample 
included pts 
with mild-to-
moderate 
hemiparesis 
in acute post-
stroke, older 
population, 
intact 
cognition, no 
sensory 
impairments, 
some 
voluntary 
motor control 
return; in-pt 
setting may 
not generalize 
to SNF; tx 
group 
intervention 
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Correlation between 
strength and ARAT 
moderate (p ≈ 0.5), poor 
with light touch, pain, 
spasticity (p ≈ 0.0, -0.1, -
0.5); ARAT and FIM 
scores not well correlated 
(measurements varied 
over 90 days, no 
numerical results given). 
Near-perfect scores on 
the ARAT does not 
necessarily signify no 
disability, clinicians may 
consider using it with 
other disability measures.  
time not 
equal; FIM 
scored over 
telephone; 
numerical 
results not 
given for all 
tests. 
Li, Lin, 
Wang, Wu, 
Huang, & 
Ouyang 
(2012) 
Examine the 
demographics 
and 3 measures 
of motor 
function in 
determining 
outcomes of 
ADL after 
distribution of 
dCIT. 
Descriptive 
correlational; 
Pyramid level: 
D2, AOTA level: 
IV 
N= 69. Inclusion: dx 
of stroke  >1 mo. prior 
to study, follow verbal 
instructions, 
Brunnstrom stage 3, 
Modified 
Ashworth Scale 2 in 
any jt. Mean time 
since stroke 16.68 mo. 
Mean age 56.56. 49 
female, 29 male. 
Pts performed dCIT 
training for 3 wks. 
Pts evaluated at 
baseline and 3 wks 
post dCIT 
intervention 
completion. 
Evaluation 
measures used: 
ARAT, FMA, 
WMFT, MAL, 
NEADL, and SIS. 
Administered by an 
occupational 
therapist. 
ARAT and FMA are 
better at predicting 
ADL/IADL outcomes 
than WMFT. ARAT 
grasp-grip-pinch 
movement score is most 
suitable predictor for 
self-report improvement 
in ADL/IADL. FMA is 
best predictor of 
participation and UE 
functional use. Age was 
the only significant 
demographic predictor 
with less reported 
improvement in older 
adults. Predictive 
validity: with NEADL 
0.273, with SIS-
Study did not 
consider 
predictive 
ability of 
assessments 
for clients 
with diverse 
cognitive 
impairment, 
family 
support, 
medication, 
mental 
health, or 
emotional 
status. 
Results may 
not apply to 
pts who 
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ADL/IADL 0.360, with 
MAL 0.443-0.454 
receive other 
interventions. 
Lin, Hsu, 
Sheu, Wu, 
Lin, Chen, 
& Hsieh 
(2009) 
To compare 
psychometric 
properties of 
UE-FMA, UE-
STREAM, 
ARAT and 
WMFT. 
Descriptive 
correlational; 
Pyramid level: 
D2, AOTA level: 
IV 
N = 35. Participants 
included in validity 
analysis. Inclusion: dx 
of first stroke, onset 
within 2 wks before 
hospital admission, 
able to follow 
instructions.  N = 30 
participants included 
in interrater reliability 
analysis. N= 30 
participants included 
in test-retest reliability 
analysis. Inclusion: >1 
yr post-stroke, stable 
medical condition, 
able to follow 
instructions; follow-up 
at 6 months.  
Two stages: 1) 
validity, interrater 
reliability, and 
responsiveness 
determined in pts 
consecutively 
admitted to a 
neurology 
department with 
sub-acute stroke; 2) 
test-retest reliability 
investigated with 
pts with chronic 
stroke recruited 
independently of 
first stage. Physical 
therapist 
administered 4 UE 
assessments and the 
BI at 14, 30, 90, 
and 180 days post-
stroke to determine 
validity and 
responsiveness. 
Two physical 
therapists 
administered the 4 
assessments 14 
days post-STROKE 
to determine 
interrater 
reliability. One 
therapist 
UE-STREAM, ARAT, 
and WMFT had 
significant floor effects at 
14 days post-stroke and 
ceiling effects at 30, 90, 
and 180 days. UE-FM 
floor and ceiling effects 
not notable and it is more 
discriminative for 
individuals with either 
very poor or very good 
motor function.  
ARAT was most 
responsive, with better 
responsiveness later in 
recovery (effect size 
0.49-0.79). 
Evidence for good 
clinical utility, test-retest 
reliability (ICC 0.99), 
concurrent and predictive 
validity across all 4 
assessments (0.81-0.97). 
Findings suggest changes 
of >3, 4, 6, and 12 points 
for UE-STREAM, 
ARAT, UE-FM, and 
WMFT, respectively, are 
unlikely to be due to 
measurement error or 
chance; authors suggest 
that the minimal 
detectable change for the 
Small sample 
size; 
considering 
severity or 
type of stroke 
in analysis 
was not 
possible. 
Age of 
participants 
lower than 
typical age of 
stroke onset 
in Taiwanese 
people, 
meaning 
Limited 
generalizatio
n of results to 
clinician 
setting; set in 
Taiwan, no 
cognitive 
impairments 
included, 
administered 
by PTs, did 
not discuss 
level of 
training for 
therapists to 
achieve IRR 
levels.  
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administered 4 
assessments twice, 
1 wk apart to 
measure test-retest 
reliability. Testing 
was random and 
counterbalanced. 
ARAT is satisfactory.  Did not use 
timed aspect 
of WMFT. 
Ng, Leung, 
& Fong 
(2008) 
To study the 
ARAT, WMFT 
and MAL in pts 
with stroke and 
UE 
impairment. 
Descriptive; 
Pyramid level:  
D2, AOTA level: 
IV 
N= 12. Seven 
participants in lower 
functioning group and 
5 in higher functioning 
group. Participants 
attended a community 
center in Hong Kong. 
Mean time since 
stroke 69.3 mo. Mean 
age 57.3. Inclusion: 
time since stroke >6 
mo., able to sit for 30 
min., no receptive 
language problems, 
can follow 1-2 step 
commands. 
ARAT, WMFT, 
MAL and FTHUE-
HK were 
administered 
among participants 
one time. ARAT 
and MAL were 
administered using 
a standardized 
approach. Only 15 
functional tasks of 
the WMFT were 
tested. Used SPSS 
and Spearman’s 
correlation 
coefficients to 
describe 
relationships 
between measures. 
Signigificance 
level: p<.05 
Participants were 
stratified into two groups 
based on results of 
FTHUE-HK. Lower 
scores on the FTHUE-
HK were good predictors 
for lower scores on the 
ARAT and WMFT. 
FTHUE-HK was highly 
statistically correlated to 
the WMFT and ARAT 
(rho = 0.92, p < 0.001). 
ARAT tests functional 
tasks and has hierarchical 
items such that subtests 
can be skipped, 
potentially saving time. 
ARAT prone to high 
floor affect; had a 
difficult time detecting 
function in pts with 
severe impairment but 
not the case with mild 
impairment. WMFT 
shown to have both floor 
and ceiling affects. 
ARAT more useful with 
high functioning pts, 
Pilot study: 
mean age is 
low relative 
to typical age 
of stroke. 
Large 
variation in 
time since 
stroke. 
Participants 
are >6 mo. 
post-stroke 
which is not 
representative 
of a typical 
subacute 
setting. Small 
convenience 
sample 
meaning 
limited 
generalizabili
ty. FTHUE-
HK designed 
to be 
culturally 
relevant for 
Hong Kong 
IDENTIFYING AND IMPLEMENTING ASSESSMENTS      30 
WMFT useful with low 
functioning pts.  
residents. 
Nijland, van 
Wegen, 
Verbunt, 
van Wijk, 
van 
Kordelaar, 
& Kwakkel 
(2010) 
To study 
concurrent 
validity 
between ARAT 
and WMFT. To 
compare their 
reproducibility, 
internal 
consistency and 
floor and 
ceiling effects. 
Association/ 
correlation; 
Pyramid level:  
D2, AOTA level: 
IV 
N= 40. Pts from 2 
rehab centers in the 
Netherlands. Dx of 
stroke. Mean age 60 
yo. Median time since 
stroke .41 yrs. 
Inclusion: hemiparesis 
of UE with some 
voluntary control, 
MMSE score > 22, no 
orthopedic UE 
limitations. 
Pts at first center 
participated in 
reproducibility 
testing, both 
therapists 
administered tests 
over one wk in 
random order; data 
from both centers 
used for internal 
consistency. 
Standardized 
method of scoring 
developed by 
Yozbatarin et al, 
was used. 
Good inter- and intra-
observer reliability for 
ARAT (0.92-0.97) and 
WMFT. More conflict of 
scores within observer 
for the WMFT than 
ARAT. Cronbach’s alpha 
score of 0.98 or higher 
for ARAT and WMFT 
show high internal 
consistency. No floor and 
ceiling effects for ARAT 
or WMFT. ARAT 
concurrent validity with 
WMFT (rho = 0.86.) 
Modest 
sample size. 
Only 
included pts 
with mild-
moderate 
stroke.  
Nordin, 
Murphy, & 
Danielsson 
(2014) 
To determine 
the intra- and 
inter-rater 
reliability of 
the (ARAT) at 
the item level 
after stroke. 
Descriptive; 
Pyramid level:   
D2, AOTA level: 
IV 
N= 35. Pts with 
impaired UE function 
post stroke. Median 
age 62 yrs, median 
time post-stroke 22 
mo. 8 female, 27 male. 
Exclusion: absence of 
active movement in 
the affected arm; other 
dx affecting UE, and 
incomprehension of 
Swedish language. 
Pts were assessed 
using the ARAT 
2xs in one day. Test 
was simultaneously 
administered and 
scored by two 
physiotherapists 
both times for each 
pt. A rank-based 
statistical method 
for paired ordinal 
data was used. 
 
Satisfactory intra- and 
inter-rater agreement 
achieved for all items on 
the ARAT (percentage 
agreement 89-94%) 
except item 19, which 
was below satisfactory. 
Non negligible 
systematic disagreements 
on 6 items were found 
within and between 
raters. No disagreement 
due to random variance 
within or between raters. 
ARAT found to be highly 
reliable. 
Only 
performed by 
two different 
therapists. 
Administered 
in Swedish 
language. All 
participants 
only had mild 
to moderately 
impaired UE 
function with 
a mean time 
post stroke of 
22 mo. 
Clinicians 
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 had up to one 
year 
experience 
using ARAT 
and up to 30 
yrs therapy 
experience. 
Van Delden, 
Peper, Beek, 
& Kwakkel 
(2013) 
Explore match 
and mis-match 
between and 
objective 
measure 
(ARAT) and 
subjective 
measures 
(MAL and SIS-
Hand) of 
improvement 
post-stroke; 
which 
participant 
determinants 
factored into 
matches 
Association/ 
correlation; 
Pyramid level:   
D2, AOTA level:  
IV; data pulled 
from early stages 
of ULTRA-stroke 
RCT (E2, I)  
N = 39. Inclusion: 
First stroke, UE 
paresis (with 10° wrist 
ext, thumb abd/ext, 
and ext in at least 2 
digits), ARAT < 53, 
age 18-80, consenting, 
motivated, no 
orthopedic limitations, 
UCO ≥ 3, MMSE ≥ 
23; mean age 61.4, 
mean time since stroke 
9.3 wks. 
Participants 
randomly assigned 
to receive CIMT, 
BATRAC, or 
conventional 
therapy for 3 wks, 
follow-up after 6 
wks; mood 
measured using the 
SIS-Emotion 
domain. 
Probability = 0.67 that 
clinically meaningful 
improvement on ARAT 
matched with meaningful 
change on MAL-QOM 
for all determinants; 
probability = 0.83 for 
match between ARAT 
improvement and SIS-
Hand improvement when 
education low (less than 
bachelor’s degree) and 
mood above normative 
score. 
Small 
sample, RCT 
data pulled 
from 
incomplete, 
no baseline 
data by 
intervention, 
ULTRA-
stroke 
inclusion 
criteria limits 
generalizabili
ty. All 
participants 
only had mild 
to moderately 
impaired UE. 
Van der 
Lee, De 
Groot, 
Beckerman, 
Wagenaar, 
Lankhorst & 
Bouter 
(2001) 
Discover intra- 
and inter-rater 
reliability of 
the ARAT. To 
assess its 
ability to detect 
a MCID. To 
discover less 
reliable test 
Descriptive 
correlational; 
Pyramid level: 
D2, AOTA level: 
IV 
N= 20, out of an RCT 
sample of N= 66. Pts 
were arranged by their 
intake ARA score and 
every 3rd pt was 
selected to be included 
in the study. Pts with 
chronic stroke, median 
age 62yrs, median 
ARAT 
administered 2xs at 
baseline, 2xs during 
2 wk therapy 
intervention phase, 
and 4 times post-
intervention. Every 
other 
administration was 
ICC and Spearman’s rho 
> 0.98, demonstrating 
high intra- and interrater 
reliability of the ARAT. 
Some items and subtests 
are easier to rate than 
others. For instance, it 
was difficult to 
distinguish between a 
Time limit on 
the difficult-
to-rate items 
is shorter 
than other 
items and 
they failed to 
ensure each 
pt’s back 
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items. time since stroke onset 
3.6yr.  Inclusion: hx of 
stroke, no severe 
cognitive impairments 
or aphasia, min. of 20 
degrees of active 
extension in the wrist 
and 10 degrees of 
finger extension. 
 
videotaped. 
Administrator 
rescored pts via 
rewatching the 
video 4-27 mo. post 
administration, and 
again 4-6 wks later. 
Pts were also 
scored via 
videotape by a 
second rater. Two 
different ways of 
scoring were 
analyzed: 1. By 
adding the score of 
all 19 tasks. 2. By 
breaking all tasks 
into four subgroup 
and testing the 
hardest task in the 
subgroup first. If pt 
passes first task, 
move on to next 
subgroup, if not, 
have pt do easiest 
task in that 
subgroup. All 19 
tasks were 
completed by all 
pts, but were 
analyzed as if it 
was administered 
using the 2nd 
protocol as well. 
score of 2 and 3 on the 
“hand to mouth” item. 
ARAT is capable of 
detecting a difference of 
at least 5.7 points, or 
10% its maximum score 
of 57 points. That MCID 
is considered clinically 
relevant. 
remained 
against the 
backrest of 
the chair 
when rating. 
The sample 
did not 
include low-
functioning 
pts. Limited 
to chronic 
stroke. All 
participants 
only had mild 
to moderately 
impaired UE. 
Van der Determine the Association/ N = 63. Inclusion: hx Participants Unidimensionality Excluded 
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Lee, 
Roorda, 
Beckerman, 
Lankhorst, 
& Bouter 
(2002) 
dimensionality 
of the ARAT, 
which method 
of the test 
(Lyle’s 
original, all 19 
items, 15 
items) is most 
efficient and 
effective. 
correlation; 
Pyramid level: 
D2, AOTA level: 
IV; data pulled 
from RCT (E2, I) 
of single stroke at least 
one yr prior, 20° ext in 
wrist, 10° ext in 
fingers, ARAT < 51, 
able to walk without 
aids, no severe 
aphasia, MMSE ≥ 22. 
Median age 61 yrs, 
median yrs since 
stroke 3.0. 
involved in forced 
use tx. 
n(intervention 
group)= 31, 
n(control group)= 
32. 
established: scalability 
coefficient of 19-item 
ARAT H = 0.79, 
reliability coefficient rho 
= 0.98 (high internal 
consistency); when 4 of 6 
pinch subtest items 
(items 1, 3, 4, 5) were 
removed, the scalability 
coefficient of the 15-item 
ARAT H = 0.83 with rho 
= 0.97, representing a 
unidimensional 
hierarchical scale; 
responsiveness ratio 
higher for 19- and 15-
item versions over Lyle’s 
original structure. These 
results show that the 
ARAT can be altered by 
omitting 4 test items and 
still be statistically 
relevant This can  
decrease the time it takes 
to administer. 
aphasia, 
sensory and 
cognitive 
impairments, 
motor return 
present in 
wrist and 
hand, limited 
to chronic 
stroke, used 
non-
standardized 
time limit on 
items. 
Yozbatiron, 
Der-
Yeghiain, & 
Cramer 
(2008) 
Present 
standardized 
approach to 
administer the 
ARAT, provide 
reliability and 
validity data for 
this approach. 
Association/ 
correlation; 
Pyramid level: 
D2, AOTA level: 
IV 
N = 12. Inclusion 
criteria: chronic stroke 
(> 3 mo prior), 
moderate R 
hemiparesis (> 10° 
ROM at MCP jt, R 9-
HPT < 75% of L), age 
> 18 yrs, R hand 
dominant. Mean age 
61 ± 15 yrs, mean time 
Study did not 
include 
intervention; 
interrater reliability 
found between 2 
therapists over 9 
participants, 
intrarater by 8 
participants over 1 
week by 1 
Interrater ICC = 0.9986, 
intrarater ICC = 0.99 
(very high for both); high 
correlation between 
ARAT and UE-FMA (r = 
0.94, P < 0.01); authors 
outline standardized 
method for 
administration in the 
appendix, including 
Limited to 
chronic 
stroke, no 
information 
on where 
participants 
recruited 
from. All 
participants 
only had 
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since stroke 34 ± 59 
mo. 
therapist, validity 
by comparison with 
the UE-FMA. 
Provides the most 
detailed manual 
with instructions on 
how to administer 
and score the 
ARAT in order to 
increase reliability. 
specific equipment and 
scoring guidelines. 
moderately 
impaired UE. 
Abbreviations Key: 9-HPT – 9-Hole Peg Test, abd – abduction, ARAT - Action Research Arm Test, BAT - bilateral arm training, BATRAC – 
bilateral arm training with auditory cueing, BI – Barthel Index, CIMT - Constraint Induced Movement Therapy, dCIT – distributed constraint-
induced therapy, dx - diagnosis, ext - extension, FMA – Fugl-Meyer Assessment, FTHUE-HK – the Functional Test for the Hemiplegic Upper 
Extremity Hong Kong version, hrs – hours, hx – history, ICC – intraclass correlation coefficient, jts – joints, L - left, MAL - Motor Activity Log, 
MAL-AOU – Motor Activity Log amount of use, MAL-QOM – Motor Activity Log quality of movement, MAS - Modified Ashworth Scale, 
MCID - minimal clinically important difference, MCP - metacarpophalangeal, MI – Motricity Index, MMSE - Mini-Mental State Examination, 
mo – month, NEADL – Nottingham Extended Activities of Daily Living questionnaire, NIHSS – National Institutes of Health Stroke Scale, pt – 
patient, PT – physical therapist, R - right, RCT – randomized controlled trial, ROM – range of motion, SBMOC – Short Blessed Memory 
Orientation and Concentration test, SIS - Stroke Impact Scale, SIS-Hand – Hand domain of the Stroke Impact Scale, SNF – skilled nursing 
facility, SRM – Standardized response mean, tx - treatment, UEMMAC - upper extremity Modified Motor Assessment Chart, UE - upper 
extremity, UE-FMA – upper extremity section of FMA, UE-STREAM – upper extremity portion of Stroke Rehabilitation Assessment of 
Movement, ULTRA-stroke – Upper Limb Training after stroke trial, UN – unilateral neglect, VAS – visual analog scale, VECTOR - Very Early 
Constraint-induced Therapy for Recovery of Stroke, wks - weeks, WMFT - Wolf Motor Function Test, WMFT-FAS - functional ability scale of 
the WMFT, WMFT-TIME - performance time on WMFT, UCO – Ultrecht Communication Observation. 
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The Arm Motor Ability Test Results 
Author, 
Year 
Study Objectives Study 
Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description 
Inclusion and 
Exclusion Criteria 
Interventions & 
Outcome Measures 
Summary of Results Study Limitations 
Kopp, 
Kunkel, 
Herta Flor, 
Platz, 
Mauritz, 
Gresser, 
McCulloch, 
& Taub 
(1997) 
Replicate AMAT 
reliability and 
sensitivity findings.  
Descriptive, 
correlational; 
Pyramid 
level: D2, 
AOTA level: 
IV 
N = 33. 12 
female, 21 male. 
Primarily in the 
subacute phase of 
stroke (median 
post-stroke days: 
43). Median age 
66 yrs. Inclusion:  
>20 degrees wrist 
flexion, 10 
degrees at MC 
and IP joints, MI 
(UE only) score 
66-99.9, MMSE 
score>19. 
Randomly assigned 
to one of two 
groups. All 
received two 
administrations of 
AMAT. Four 
components of 
original AMAT not 
included. 
Administrations 
were either 1 or 2 
weeks apart, 
depending on the 
group. 
13/17 timed, 
compound ADL 
tasks were 
evaluated. 
Measures: 
AMAT (Functional 
ability, quality of 
movement, and 
performance time) 
& MI. 
Interrater reliabilities 
for the AMAT were 
high (Kappas: 0.68-
0.77), Spearman 
coefficients of 0.95 or 
above). Test-retest 
reliability: 0.93-0.99. 
Homogeneity of 
AMAT very good. 
Internal consistency 
close to unity. 
Concurrent validity 
with UE portion of MI 
is satisfactory (r=0.61), 
but AMAT is 
internally consistent 
whereas MI is not. 
Sensitivity to change 
in pts’ motor control 
was determined by 
comparing patients’ 
test-retest data of 1-
week and 2-week 
groups. Determined 
test could be shortened 
without affecting 
reliability or 
sensitivity.  
Complete AMAT was 
not used in research. 
AMAT was compared 
to an assessment with 
mediocre internal 
consistency. Therefore, 
the concurrent validity 
cannot be derived from 
this study alone. Did 
not include low 
physical and/or low 
cognitive functioning 
pts.  
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O’Dell, 
Kim, 
Rivera, 
Fieo, 
Christos, 
Polistena, 
Fitzgerald, 
& Gorga 
(2013) 
 
Explore 
psychometrics of a 
9-item version of 
AMAT, to 
determine 
appropriateness for 
use with pts with 
stroke and severe 
impairments as 
sequelae.  
Descriptive, 
correlational; 
Pyramid 
level: D2, 
AOTA level: 
IV 
N = 32. 9 female, 
23 male. 35-85 
yrs old. 88% 
Right-handed 
with post-stroke 
range 0.8-25.2 
yrs. Inclusion: >6 
mo. post-stroke, 
able to follow 
directions, 
adequate vision, > 
3 mo. since rehab 
tx or botulinum 
injection, 
adequate PROM 
to participate in 
robotics therapy, 
MM strength 1-⅘ 
for all UE joints. 
WMFT, ARAT, 
FMA, and AMAT-
9 assessments 
administered by 
single researcher at 
baseline and 
following 12 weeks 
of robotics 
treatments. SIS was 
completed by 
participants at 
home with family 
or in the clinic with 
a researcher. The 
assessment scores 
were compared 
through statistical 
analysis methods. 
Participants 
demonstrated severe 
functional deficits 
overall. Reliability of 
AMAT-9 was good. 
Correlation 
coefficients between 
AMAT-9 and ARAT, 
FMA, and WMFT 
were significant and 
identical (0.78-0.79, 
p<0.001). AMAT 
demonstrated 
intermediate 
responsiveness 
compared to other 
assessments. 
AMAT considers 
compensatory 
behaviors unlike BI 
and FIM. 
Unidimensionality of 
AMAT-9 supported by 
independent t-tests 
(6.25% fell outside 
1.96 +/- range). 
Characteristics are also 
consistent with a 
Rasch model. Rasch 
analysis demonstrated 
hierarchical item 
difficulty. 
Participants not 
randomly selected. 
Participants were 
primarily young 
motivated individuals 
interested in 
participating after other 
treatment options were 
exhausted. Most 
participants had 
moderate to severe UE 
functional limitations. 
Assessor was not 
blinded to the study 
design or hypotheses. 
Scales were not 
randomly administered. 
Participants may not 
reflect the population 
typically seen in a 
subacute setting (>6 
mo. post-stroke).   
O’Dell, 
Kim, 
Finnen, & 
After reviewing 4 
studies the 
researchers 
Literature 
Review; 
Pyramid 
An unspecified 
number of articles 
were included. 
Descriptive 
information about 
the content 
Test is easy to 
administer, 
inexpensive, and uses 
Information about the 
quality of articles was 
not included; therefore, 
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Polistena 
(2011)  
 
 
Including 
studies by: 
McCulloch, 
1988 
Kopp, 1997 
Chae, 2003 
Daly, 2005 
provided an 
overview of current 
use of the AMAT 
including content 
evolution and 
provide 
recommendations 
for future use. 
 
 
level: D1, 
AOTA level: 
I 
  
 
Inclusion: Studies 
that addressed 
clients with stroke 
and considered 
psychometrics of 
AMAT and/or 
that included 
AMAT as an 
outcome measure. 
evolution and 
psychometrics of 
the AMAT alone, 
including 
comparisons 
between different 
versions of the 
AMAT. 
Comparison of the 
psychometrics and 
outcomes of the 
AMAT, BI, FMA, 
SIS, FIM, and 
WMFT. 
everyday task objects. 
The administrator must 
be skilled in 
multitasking in order 
to score. The test 
allows for bilateral 
arm use, so even pts 
with little hand 
function should have 
some success. 
Strong psychometrics 
for full and shortened 
version: test-retest and 
interrater reliability 
coefficients: 0.68-1.0; 
ICC: 0.94-0.97. 
Significant 
correlations between 
AMAT and other 
assessment scores (e.g. 
0.75-0.90 with FMA). 
Sensitivity and 
responsiveness are not 
well established. FA 
should be only domain 
assessed since Kopp et 
al, found psychometric 
redundancy between 
FA and QOM, and 
Chae et al. found 
significant floor and 
ceiling affects for 
performance time and 
AMAT underestimated 
motor control in pts 
with severe 
it is difficult to 
confidently accept the 
positive claims and 
recommendations 
pertaining to the 
AMAT from this 
review alone. Could not 
speak to sensitivity or 
MCID of AMAT. 
Researchers did not 
document search 
strategy or results of the 
review. It would be 
difficult to replicate this 
review and its 
comprehensiveness 
cannot be determined. 
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impairment. 
Rowland & 
Gustafsson 
(2008).  
Review the 
literature of UE 
assessments used 
for stroke pts, 
analyze 
assessments to 
determine clinical 
utility, and rate 
each assessments 
psychometrics 
data. 
Descriptive, 
systematic 
review; 
Pyramid 
level: D1, 
AOTA level: 
I 
N=7 assessments 
including WMFT, 
AMAT, ARAT, 
MAL, UL-MAS, 
ABILHAND, & 
CAHAI. Criteria: 
UE ability 
assessment, >1 
test item tests 
ADL, 
psychometric data 
included pts with 
stroke, measures 
that use 
quantitative data, 
assessments 
administered by 
occupational 
therapists.   
Criteria for measure 
analysis: Purpose of 
measurement, 
clinical utility, 
measurement 
construction, 
standardization, 
reliability, and 
validity. 
Assessments 
analyzed using 
modified criteria of 
Outcome Measures 
Rating Forms and 
Guidelines.  
 
Psychometrics of all 
measures rated as 
adequate to excellent. 
Reliability for AMAT 
based on studies 
included in review: 
adequate. Validity for 
AMAT rated excellent. 
AMAT detected 
difference in change 
with passing of 1 vs. 2 
weeks. Floor and 
ceiling effects for 
clients with severely 
impaired or near-
normal UE function. 
ARAT able to detect 
clinically relevant 
change at 5.7 points. 
ARAT responsiveness 
indices: rho=0.66, 
d=0.52. ARAT 
responsiveness ratio: 
2.03. 
Studies that looked at 
AMAT excluded 
participants unable to 
extend their wrist >20 
degrees and MP joints 
>10 degrees.  
Study lacked thorough 
discussion of the search 
strategy, especially 
with respect to articles 
or studies included in 
this review. Studies 
could have been 
selected to focus on 
strengths and minimize 
weaknesses of the 
measures.  
Abbreviations Key: ADL - activities of daily living, AMAT - Arm Motor Ability Test, AMAT-9 - 9-item Arm Motor Ability Test, AOTA - 
American Occupational Therapy Association, ARAT - Action Research Arm Test, BI - Barthel Index, CAHAI – Chedoke Arm and Hand Activity 
Inventory, CMSA - Chedoke McMaster Stroke Assessment, FA -  functional ability, FAT - Frenchay Arm Test, FIM - Functional Independence 
Measure, FMA - Fugl-Meyer Assessment, IP - interphalangeal, MAL – Motor Activity Log, MC - metacarpal, MI - Motricity Index, MM - manual 
muscle, MMSE - Mini Mental State Examination, PROM - passive range of motion, pt - patient, QOM - quality of movement, SIS - Stroke Impact 
Scale, UE - upper extremity, UE-MAS – Upper Limb Motor Assessment Scale, WMFT - Wolf Motor Function Test  
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The Chedoke Arm and Hand Activity Inventory Quantitative Results 
Author, 
Year 
Study 
Objectives 
Study 
Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description Inclusion 
and Exclusion Criteria 
Interventions & 
Outcome Measures 
Summary of Results Study Limitations 
Barecca, 
Stratford, 
Lambert, 
Masters, & 
Streiner 
(2005) 
Estimate test-
retest reliability 
and validity of 
the CAHAI. 
Test if CAHAI 
was more 
sensitive to 
change in upper 
limb function 
than CMSA or 
ARAT. 
 
Association/ 
correlation;  
Pyramid 
level: D2, 
AOTA 
level: IV 
N=39. Participants had 
suffered a stroke and 
receiving therapy in an 
inpatient or outpatient 
facility. 19 female, 20 
male. n = 15 (chronic/ 
severe, n = 24 
(acute/mild-moderate 
stroke). Mean age 
(acute) 71.4 yrs. Mean 
age (chronic) 64 yrs. 
Mean time since onset 
(acute) 27.3 days. 
Mean time since onset 
(chronic) 101.7 days. 
Exclusion: LMN 
injury, UE injury pre-
stroke, not enough 
stamina to 
participate.   
Pts were assessed 
using the CMSA and 
the CAHAI at 
baseline and 2 to 6 
wks later. The ARAT 
was used at baseline 
and follow-up. ICC 
was determined. 
Construct and 
discriminant validity 
of CAHAI was 
assessed. 
ICC for CAHAI was 
.98, which shows high 
interrater reliability. 
Convergent and 
discriminant validity 
of CAHAI was 
supported. It was 
found that CAHAI is 
better at distinguishing 
change than the 
CMSA arm-hand sum 
and the ARAT.  
Small sample size. 
Time of 
reassessment varied 
a lot per pt.  
Therapy setting 
varied among pts.  
Barreca, 
Stratford, 
Masters, 
Lambert & 
Griffiths 
(2006) 
To determine if 
the validity of 
scores were 
greater for 2 
versions of the 
CAHAI or for 
the ARAT. To 
determine if 
Association/ 
correlation; 
Pyramid 
level: D2, 
AOTA 
level: IV 
N=105. Participants 
were pts at 1 of 4 
rehab facilities. 51 
female, 54 male. 
Inclusion: stroke pt. 
Exclusion: LMN 
injury, UE injury pre-
stroke, not enough 
CAHAI-13 was 
administered to 
participants upon 
initial eval and 
discharge from OT or 
PT. A research 
therapist also 
administered the 
Both versions of 
CAHAI had identical 
levels of cross-
sectional validity. 
Receiver operating 
characteristic curve 
areas significantly 
greater for CAHAI 
Pts were not 
actually 
administered the 
CAHAI-9, yet 
results were 
gathered as if they 
did. Pts received 
therapy in different 
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validity of the 
scores on the 
CAHAI-13 
were greater 
than the 
CAHAI-9. 
stamina, combined 
arm and hand CMSA 
score >11. 
CAHAI-13, as well 
as the ARAT within 
36 hrs of the 
therapist. CAHAI-9 
scores were 
abstracted from 
CAHAI-13 scores 
because the 9 tasks 
from the CAHAI-9 
assessment are 
included in the 
CAHAI-13 
assessment. 
versions compared to 
ARAT, showing 
greater sensitivity to 
change.  
settings, thus 
creating another 
variable, though it 
could also improve 
generalization.   
Barreca, 
Stratford,  
Masters, 
Lambert, 
Griffiths, 
McBay 
(2006) 
To 
determine         
reliability and 
validity of 3 
shortened 
versions of the 
CAHAI. 
 
Association/ 
correlation; 
Pyramid 
level: D2, 
AOTA 
level: IV 
N= 39; n (acute 
stroke)= 24, n (chronic 
stroke)= 15. 
Exclusion: LMN 
injury, UE injury pre-
stroke, CMSA score > 
11, not enough 
stamina. Median 
number of days since 
stroke 27.3 acute, 
101.7 chronic. Median 
age 71 yrs acute, 64 
yrs chronic.  
Item reduction of 
CAHAI-13 was 
conducted in order to 
create 3 shortened 
versions. Treating 
therapist and research 
therapist both 
administered 
CAHAI-13 upon 
eval. Research 
therapist administered 
ARAT and treating 
therapist administered 
CMSA upon eval. 
Later, after pt 
received therapy, 
research therapist 
administered ARAT 
and treating therapist 
administered CMSA 
and CAHAI-13. Data 
gathered was used to 
Internal consistency: 
CAHAI-13: .98, 
CAHAI-9: .98, 
CAHAI-8: .98, 
CAHAI-7: .97, thus 
the test items relate 
well to each other. 
Test-retest reliability: 
CAHAI-13: .98, 
CAHAI-9: .97, 
CAHAI-8: .97, 
CAHAI-7: .96. High 
test-retest reliability 
for all. ROC curve: 
CAHAI-13: 0.95, 
CAHAI-9: 0.94,  
CAHAI-8: 0.93 
CAHAI-7: 0.97. All 
very sensitive to 
change. Clinicians 
who administered 
CAHAI recommended 
Small sample size. 
Setting was not 
mentioned and may 
have varied among 
pts.  
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assess cross-sectional 
and longitudinal 
validity of shortened 
versions of CAHAI. 
the CAHAI-9, as it 
included important 
tasks that the shorter 
version cut out, while 
still maintaining 
accurate statistical 
findings.   
Rowland, 
Gustafsson, 
Turpin,  
Henderson, 
& Read 
(2011) 
To investigate 
clinical utility 
of CAHAI-9 in 
an acute stroke 
setting. 
Association/ 
correlation; 
Pyramid 
level: D2, 
AOTA 
level: IV 
N= 32. Participants 
were occupational 
therapists from 8 
hospitals working in 
acute medical or 
stroke setting. 31 
female, 1 male. Yrs of 
neuro experience: <1 
yr: 13, 1-5 yrs: 10, 5+ 
yrs: 9. 
Participants 
completed 100 
CAHAI-9 
assessments on 92 pts 
with stroke over 6 
mos. They also 
completed 
questionnaires 
regarding clinical 
utility of CAHAI-9. 
Questions included: 
mean administration 
time, # of pts 
assessed by bedside, 
and mean scores.   
Test item 9 (cutting 
putty) presented the 
greatest difficulties- 
53% said overall, it 
was too difficult for 
pts to perform. Test 
item 2 (dialing 911) 
was not applicable to 
Australian pts. 75% of 
participants planned to 
use CAHAI-9 in the 
future. Mean 
administration time for 
CAHAI: 16.2 minutes. 
Clincians were 
relatively 
inexpereinced in 
neuro, only 25% 
had main case load 
of acute stroke. 
Abbreviations Key: ARAT- Action Research Arm Test, CAHAI- Chedoke Arm and Hand Activity Inventory, CMSA- Chedoke-McMaster Stroke 
Assessment, eval - evaluation, hr - hour, ICC – intraclass correlation coefficient, LMN – lower motor neuron, pt - patient, UE – upper extremity 
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The Chedoke Arm and Hand Activity Inventory Qualitative Results 
Author, 
Year 
Study Objectives Study 
Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description Inclusion 
and Exclusion Criteria 
Methods for enhancing 
rigor 
Themes and Results Limitations 
Gustafsson, 
Turpin, 
Dorman 
(2010) 
To explore the 
clinical utility of 
the CAHAI 
when used by 
occupational 
therapists in 
stroke 
rehabilitation. 
 
Qualitative; 
Pyramid 
level: Q3 
rigor-(b, d), 
AOTA level: 
V 
N=13. 10 female, 3 
male.  
Participants were 
occupational 
therapists working in 
stroke rehab settings. 
8 participants had 
been trained in 
administration of the 
CAHAI (group A), 5 
had not (Group B). 
Participants had been 
working for 7.5 ± 8.5 
yrs. 
 
Participants took part 
in 25 min focus group. 
They watched a video 
of a client being 
assessed using the 
CAHAI. They then 
scored the client. 
Discussion questions 
about utility of CAHAI 
followed. Thematic 
coding categories were 
determined from the 
discussion portion by 3 
independent raters.  
Themes: “Instructions 
ambiguous and scoring 
unclear”, “how we use it”, 
“whole task versus motor 
components”, “knowing 
when to use it”, “detecting 
other impairments”, 
“changing the way clients 
do tasks” and “how they 
analyze tasks”. Some 
therapists use the CAHAI 
as an intervention tool. 
Some therapists used 
components of the CAHAI 
to assess factors other than 
UE impairments. 
 
Clinicians did 
actually not 
administer the 
CAHAI. Study 
was only 25 
minutes in 
length, thus 
some themes 
may be 
missing.   
Abbreviations Key: CAHAI- Chedoke Arm and Hand Activity Inventory, min – minute, pt - patient, UE – upper extremity, yr - year.  
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The Motor Evaluation Scale for Upper Extremity in Stroke Patients Results 
Author, 
Year 
Study Objectives Study Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description 
Inclusion and 
Exclusion Criteria 
Interventions & 
Outcome Measures 
Summary of Results Study 
Limitations 
Van de 
Winckel, 
Feys, 
Messerli, 
Baronti, 
Lehmann, 
Hemelrijk, 
Pante, 
Perfetti, & 
Weerdt 
(2006) 
Explored the 
validity and 
unidimensionality 
of the MESUPES 
using Rasch 
analysis as well as 
interrater 
reliability. 
 
Outcomes 
pre-post 
study; 
Pyramid 
level: O4, 
AOTA level: 
IV 
N= 396 in the 
Rasch study, 158 
female, 238 male, 
and from that 
sample, N = 5, 25 
female, 31 male in 
the reliability 
study. Mean age 
63-65 yrs. Average 
time since stroke 
7.18 +/-16.36 mos. 
Participants were 
pts at one of 12 
facilities in either 
Germany, Belgium 
or Switzerland. 
Inclusion: 1) No 
other neurological 
conditions, 
orthopedic, or 
rheumatic 
impairments, 2) No 
contractures of the 
UE, 3) No neglect 
or apraxia, 4) Able 
to understand and 
follow instructions.  
All pts were tested by 
1 of 7 evaluators who 
each received one hour 
of MESUPES training. 
Rasch Analysis 
performed on arm 
function and hand 
function components 
separately. 56 of those 
pts were evaluated by 
two assessors to 
determine interrater 
reliability; second 
assessment was 
administered 24 hrs 
after the first. Interrater 
reliability was 
investigated using 
weighted percentage 
agreement, ICC, and 
kappa values.  
MESUPES measures the 
quality of movement. 
Weighted percentage 
agreement (>85.7%) and 
Kappa values were high 
(0.62-0.79) suggesting 
high reliability. Initial 
analysis determined 
MESUPES is a 
multidimensional 
measure. All response 
categories demonstrated 
logical order of 
increasing difficulty. 
Three hand items and 
two arm items did not fit 
the Rasch model. After 
removing those items, 
both subscales fit the 
model suggesting good 
internal construct 
validity and 
unidimensionality.  
Average age of 
pts in this study 
is young 
compared to the 
general 
population of 
stroke pts. 
This study did 
not include 
comparisons to 
other scales in 
the analysis. 
Study was 
performed in 
Europe.   
Johansson Determine inter- Descriptive N= 42. 15 female, An updated version of Linear-weighted k Moderate sample 
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& Häger 
(2012) 
rater reliability, 
estimate the MDC, 
and investigate the 
concurrent validity 
of the MESUPES.  
correlational; 
Pyramid 
level: D2, 
AOTA level: 
IV 
27 male. Mean age 
56 yrs. Most in 
chronic phase. 
Median time post-
stroke 7 mos, mild-
to-severe deficits. 
Inclusion: 1) No 
other neurological, 
orthopedic, or 
rheumatic 
conditions, 2) No 
UE contractures, 3) 
No neglect or 
apraxia, 4) Ability 
to understand and 
follow instructions. 
the MESUPES was 
used, breaking the 
assessment into an arm 
scale and a hand scale. 
All pts tested on the 
MESUPES by two (out 
of four) random, 
trained 
physiotherapists. 
Second test 
administered within 48 
hrs of the first. Inter-
rater reliability 
determined by 
percentage of 
maximum one-score 
difference, linear-
weighted k analysis, 
and percentage of 
agreement. Spearman’s 
rho calculated between 
MESUPES and UE 
MAS to determine 
concurrent validity. 
MDC calculated using 
SEM and assessment 
data. 
values (0.63-0.96) 
indicating good to very 
good inter-rater 
reliability. K-value of 
>0.86 on 10 out of 17 
items. Score differences 
on items was <2. Very 
high correlation based 
on ICC of >0.98 for 
subscores and total 
score. Sufficient 
absolute reliability 
determined by SEM of 
2.68. Correlation score 
of r = 0.87 for 
MESUPES and the UE 
M MAS indicate good 
concurrent validity. 
Score change of 5, 7, 
and 8 is required to 
achieve 80%, 90%, and 
95% confidence. MDC% 
for MESUPES is 
sufficiently low (18%). 
size of chronic 
phase stroke 
survivors means 
generalizability 
is limited. 
This study did 
not consider 
intra-rater 
reliability or 
sensitivity of the 
MESUPES. 
Study was 
completed in 
Europe.  
Raters had no 
prior experience 
with this 
measure. Raters 
had two hours of 
training. 
Abbreviations Key: AOTA – American Occupational Therapy Association, hrs – hours, ICC – intra-class correlation, K-value – kappa value, 
MDC – minimal detectable change, MESUPES – Motor Evaluation Scale of Upper Extremity in Stroke Patients, M MAS- Modified Motor 
Assessment Scale, pt = patient, SEM – standard error of the mean, UE - upper extremity  
The Streamlined Wolf Motor Function Test Results 
Author, Year Study 
Objectives 
Study Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description 
Interventions & 
Outcome Measures 
Summary of Results Study 
Limitations 
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Inclusion and 
Exclusion 
Criteria 
Bogard, Wolf, 
Zhang, 
Thompson, 
Morris, 
Nichols-Larsen 
(2009) 
Determine if it 
is possible to 
streamline the 
WMFT by 
defining only 
those items 
that showed 
greatest 
improvement 
relative to the 
entire test. 
Descriptive; 
Pyramid level:  
D2, AOTA level: 
IV; data drawn 
from larger RCT 
(E2, I) 
N = 169; 
n(immediate 
group) = 96, 
n(delayed group) 
= 73. All 
participants in 
EXCITE trial 
from 6 university 
programs. 
Inclusion: 1st time 
stroke, thumb and 
2 digits ≥ 10°, 
transfer 
independently, 
stand for 2 min; 
no cognitive 
impairments or 
unstable medical 
status, only 
participants who 
completed all tx.  
Participants 
randomized into 
immediate tx group 
or delayed tx (I yr 
later) group; tx 
involved safety mitt 
on less affected 
limb for 90% of 
waking hours for 14 
consecutive days 
and ATP and RTP 
progressing to 6 
hrs/day for 10 days 
total; WMFT given 
by trained therapists 
at baseline, post-tx, 
and every 4 mo for 
2 yrs, videotaped for 
rating by 
independent 
therapists; 
covariates included 
gender, functional 
level, concordance. 
Log mean scores for change 
scores calculated, covariates 
controlled for; immediate 
group showed significant (p 
< 0.05) relationships with 6 
timed items: hand to table 
(front), hand to box (front), 
reach and retrieve, lift can, 
lift pencil, fold towel; 
delayed group showed 
significant (p < 0.05) 
relationships with 6 timed 
items; extend elbow weight 
hand to box (front), lift can, 
lift pencil, turnkey in lock, 
fold towel. The authors 
conclude that the two 
streamlined versions of the 
WMFT are viable for 
assessing function and 
tracking change.  
Little 
demographic 
information 
provided, mild 
to moderate 
stroke severity, 
delayed group 
received other 
tx during yr 
before CIMT, 
no reliability or 
validity done 
on proposed 
streamlined 
version, 
EXCITE 
inclusion 
criteria not met 
by most stroke 
survivors; 
streamlined 
version specific 
to stroke 
recovery 
stages. 
Chen, Wu, Lin, 
Chen, Chen, & 
Chen (2012) 
Examined 
psychometrics 
of subacute 
and chronic 
versions of the 
S-WMFT. 
Outcomes, pre-
post (part of an 
RCT E2, I); 
Pyramid level: 
O4, AOTA level: 
III 
n(chronic phase 
stroke)= 97. 33 
female, 64 male. 
Median age 56.6 
yrs, median time 
post-stroke 20 
Three trained 
occupational 
therapists 
administered 
WMFT before and 
after participation in 
Unidimensionality 
determined. No significant 
DIF by demographics found 
in either version. Subacute 
stroke version did not 
measure UE motor function 
Sample size is 
moderate and 
limited to mild 
and moderate 
stoke severity, 
which limits 
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mo. n(subacute 
stroke)= 75. 17 
female, 58 male. 
Median age 55.6 
yrs, median time 
post-stroke 7 mo. 
Inclusion: First-
time stroke with 
onset 3-9 mo. 
prior (subacute) 
or >12 mo. prior 
(chronic), Ability 
to understand and 
respond to 
questions, MMSE 
score >22, 
Brunnstrom stage 
> 3 for proximal 
affected UE, 
score ≤ 2 on 
Modified 
Ashworth Scale. 
rehabilitation 
programs. 
Outcomes included 
test structure, 
targeting, reliability, 
and item difficulty 
hierarchy. Construct 
validity, 
unidimensionality, 
and correlations 
between items were 
also investigated 
through data (and 
Rasch) analysis. 
Researchers tested 
DIF to determine 
how demographics 
influence test 
outcomes. 
as well as chronic version. 
Item correlation coefficient 
range: 0.37-0.74 meaning 
that the items measure 
similar UE motor 
components. Some 
redundancy of items was 
found in the subacute 
version and the authors 
recommended removal of 
1of the 2 highly correlated 
items (move hand to box 
and move hand to table). 
Both versions are useful 
measures for pts with mild 
to moderate impairment 
post-stroke.  
generalizability 
to facilities that 
also treat more 
severe stroke 
survivors.  
 
Did not include 
participants 
with severe 
impairments, 
also limiting 
the external 
validity.   
Chen, Wu, Lin, 
Jang, Lin, 
Cheng, Chung, 
& Yan (2014) 
Can the 
SWMFT-C and 
SWMFT-S be 
used in for pts 
>12 mo and 3-
9 mo post-
stroke, do the 
two tests cover 
a continuum of 
recovery? 
Association/ 
correlation; 
Pyramid level: 
D2, AOTA level: 
IV 
N = 351, drawn 
from ongoing 
studies at 6 
hospitals. 
Inclusion: 
Brunnstrom ≥ 2 
proximal and 
distal, MMSE ≥ 
18, first time 
stroke, no major 
medical problems 
(aphasia, visual 
deficits, poor 
Participants 
received one of 
following txs for 90 
min/day for 3 or 4 
wks: conventional 
rehabilitation, BAT, 
dCIT, robot-assisted 
therapy, mirror 
therapy; 17-item 
WMFT 
administered by 
trained independent 
therapists; 4 
Unidimensionality: PCA of 
residuals showed that the 
Rasch model explained 
72.2% of the varience, 
indicating 
unidimensionality; Rasch 
analysis also found the item 
hierarchy of the SWMFT 
was similar to the WMFT 
(items were ordered from 
least to most difficult); 
average difficulty of 
SWMFT items covered full 
Only assessed 
FAS of 
SWMFT, some 
motor return 
present, no 
severe 
cognitive 
impairments, 
limited to mild 
to moderate 
stroke severity, 
took place in 
Taiwan.  
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physical 
condition), split 
into 3 groups: 
acute (mean age 
53.23 ±12.83 
yrs), 9-12 mo 
(53.67 ± 11.46), 
chronic (54.85 ± 
11.23). 
overlapping items 
from two SWMFT 
tests and 4 unique 
items combined into 
8 items reviewed in 
this study. 
range of UE function (from 
-1.49 to 1.59 logits), overall 
range of SWMFT items -
8.38 to 7.80 logits; both the 
SWMFT-S and the 
SWMFT-C can be used 
accurately with pts 9-12 mo. 
post-stroke. 
Wu, Fu, Lin, 
Feng, Hsieh, 
Yu, Lin, Hsieh, 
& Ota (2011) 
Determine 
responsiveness, 
concurrent 
validity, and 
predictive 
validity of the 
S-WMFT as 
compared to 
the WMFT. 
Descriptive; 
Pyramid level: 
D2, AOTA level: 
IV 
N = 64, 54 
participants from 
previous study by 
authors, 10 
additional 
recruited from 
rehab 
departments at 3 
hospitals. 
Inclusion: first 
time stroke 3-10 
mo. prior, 
Brunnstrom ≥ III 
for proximal 
affected limb, 
MMSE > 24, 
MAS ≤ 2, no 
other major 
medical problems 
(apahsia, low 
vision, poor 
overall health). 
Mean age 53.01 ± 
12.75 yrs, mean 
time since stroke 
7.88 ± 1.69 mo. 
Randomly assigned 
to 1 of 3 
interventions for 2 
hr/day for 3 wks: 
dCIT, BAT, or 
conventional 
therapy; evaluated 
at baseline and 
immediately after tx 
by 3 trained OTs; 
responsiveness 
found using 
Wilcoxon signed 
rank test, validity by 
correlation with the 
FMA and SIS-Hand 
(Spearman rank 
correlation 
coefficient), 
predictive validity 
by tracking change 
from baseline to 
post-test. 
Responsiveness: both tests 
small to moderate (S-
WMFT effect size d = 0.41, 
WMFT effect size d = 0.52), 
no statistically significant 
difference between the two 
tests 
Concurrent validity: S-
WMFT had good 
correlation with FMA (ρ = 
0.69 at baseline, 0.58 at 
post-test) and good with 
SIS-Hand (ρ = 0.59 at 
baseline, 0.57 at post-test); 
WMFT had good 
correlation with FMA (ρ = 
0.64 at baseline, 0.64 at 
post-test) and with SIS-
Hand (ρ = 0.51 at baseline, 
0.54 at post-test) 
Predictive validity: both test 
correlated significantly with 
the FMA and SIS-Hand (ρ ≥ 
0.56, p < 0.01), very little 
difference between the two 
tests.  Authors conclude that 
No cognitive 
impairments, 
high level of 
arm function 
present, limited 
range of time 
since stroke; no 
reliability data 
included, sub-
acute stroke 
only. 
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both versions of the S-
WMFT are acceptable 
measures for detecting 
change in movement ability 
and predicting return of 
motor function. Compared 
to the original test, the 
streamlined tests have 
similar sensitivity and 
concurrent validity, and 
better predictive validity 
and clinical utility. 
Abbreviations Key: ATP – adaptive task practice, BAT – bilateral arm training, dCIT – distributed constraint-induced therapy, DIF – differential 
item functioning, FMA – Fugl-Meyer Assessment, hr - hour, MAS – Modified Ashworth Scale, min - minute, MMSE – Mini-Mental State 
Examination, mo. – month, OT – occupational therapist, PCA – principal component analysis, pt - patient, RCT – randomized controlled trial, 
rehab – rehabilitation, RTP – repetitive task practice, SIS-Hand – hand section of the Stroke Impact Scale, S-WMFT – Streamlined Wolf Motor 
Function Test, SWMFT-FAS – Streamlined Wolf Motor Function Test Functional Ability Scale, SWMFT-C – Streamlined Wolf Motor Function 
Test Chronic, SWMFT-S – Streamlined Wolf Motor Function Test Sub-acute, tx - treatment, UE – upper extremity, wk - week, WMFT – Wolf 
Motor Function Test, yr – year 
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Stroke Descriptive Review Results 
Author(s), 
Year 
Study 
Objectives 
Study 
Design/ 
Level of 
Evidence 
Assessments 
or Screens 
Being 
Compared 
Psychometrics Population/ 
Setting 
Summary of 
Results 
Limitations 
Lang, Bland, 
Bailey, 
Schaefer, & 
Birkenmeier, 
2013. 
To provide 
an approach 
for assessing 
the UE post-
stroke.  
Descriptive 
review; 
Pyramid 
level: D3, 
AOTA 
level: V  
ARAT, BBT, 
CAHAI, JTT, 
NHPT, 
WMFT, 
MAL, SIS.  
Interrater reliability: 
ARAT- .98, BBT- 
.99, CAHAI- .98, 
JTT- 0.82 to 1.00, 
NHPT- 0.68 to 0.99, 
WMFT- 0.85 to 
0.97. Test-retest 
reliability: ARAT- 
.98, BBT- .96, 
CAHAI- 0.96 to 
0.97, NHPT- 0.68 to 
0.99, WMFT- 0.94 
to 0.99, MAL- 0.79 
to 0.82, SIS- 0.70 to 
0.92.  
All of these 
assessments 
are for use on 
pts with 
stroke and 
can be 
performed in 
any rehab 
setting.  
The assessments 
are all strong and 
all measure UE 
function. All of 
them are 
recommended for 
clinical use. 3 
questions help 
choose 
appropriate 
assessment: Is 
equipment 
available? Is 
training needed? 
How long to 
administer?  
Nothing is 
mentioned 
specifically about 
the studies that were 
done in order to 
glean psychometric 
data for the 
assessments, thus 
limitations are 
unknown.  Inclusion 
and exclusion 
criteria were not 
discussed, and there 
was limited data 
provided on the 
included studies.  
Poole & 
Whitney 
(2001) 
Review 
assessments 
of motor 
function that 
are 
appropriate 
for post-
stroke pts. 
Systematic 
Review; 
Pyramid 
level: D1, 
AOTA 
level: V  
 
 
FMA, MAS, 
RMA, 
CMSA, 
MCA, MI, 
STREAM, 
FAT, ARAT, 
FT, and 
AMAT.  
Interrater reliability: 
FMA-.96, MAS- .95 
to .99, RMA- t = 
.80, CMSA- .97, 
MI- spearman’s rho 
= .88, STREAM- 
GCC= .96 to.99, 
FAT- 100% 
agreement, ARAT- r 
= .98 and .99, FT- 
spearman’s rho = 
.97, AMAT- 
spearman’s rho = 
All of these 
assessments 
are for use on 
pts with 
stroke and 
can be 
performed in 
any rehab 
setting.  
Test-retest 
reliability is high 
for the AMAT 
compared to 
others such as the 
FAT and CMSA, 
and ARAT. Intra-
rater reliability 
was at least 
adequate for all 
11 assessments.  
FMA, RMA, 
CMSA, and FT 
Lacks discussion of 
how articles and/or 
studies were 
selected to be 
included in this 
review including the 
samples, 
interventions, and 
other influential 
aspects of studies 
that could have 
influenced the 
psychometric data. 
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.69 to.99. Intrarater: 
FMA- r = .98, 
MAS- r = .98, 
CMSA- .98 total 
score, ARAT- r = 
.99. 
take long to 
administer, not 
advised. FMA, 
RMA, CMSA, 
and AMAT more 
sensitive to 
change than 
MAS, MCA, MI, 
STREAM, FAT, 
ARAT, and FT.  
It is 
recommended 
that an assessment 
of motor activity 
ability be used 
concomitant with 
functional 
participation 
assessments such 
as the Barthel and 
FIM.  
Lacks discussion of 
the process of 
determining which 
assessments fit the 
inclusion criteria as 
well as a lack of 
discussion in terms 
of the quality of 
each study. 
Abbreviations Key: AMAT- Arm Motor Ability Test, ARAT- Action Arm Research Test, BBT- Box and Block Test, CAHAI- Chedoke Arm and 
Hand Activity Inventory, CMSA- Chedoke-McMaster Stroke Assessment, FIM- Functional Independence Measure, FMA- Fugl-Meyer 
Assessment, FT- Functional Test for the Hemiparetic Extremity, GCC- generalizability correlation coefficient, JTT- Jebson-Taylor Hand Function 
Test, MAL- Motor Activity Log, MAS- Motor Assessment Scale, MCA- Motor Club Assessment, MI- Motricity Index, NHPT- Nine-Hole Peg 
Test, RMA- Rivermead Motor Assessment, SIS- Stroke Impact Scale, STREAM- Stroke Rehabilitation Assessment of Movement, WMFT- Wolf 
Motor Function Test.  
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Stroke Systematic Review Results 
Author, 
Year 
Study Objectives Study 
Design/ 
Level of 
Evidence 
Number of Papers 
Included, Inclusion 
and Exclusion 
Criteria 
Interventions & 
Outcome Measures 
Summary of Results Study Limitations 
Murphy, 
Resteghini, 
Feys, 
& Lamers 
(2015) 
To discover 
Psychometric 
properties and 
clinical utility of 
UE outcome 
measures for 
stroke pts via 
systematic 
review. 
Systematic 
review (of 
systematic 
reviews); 
Pyramid 
level: D1, 
AOTA level: 
I  
Systematic search 
included systematic 
reviews from 2004 
to February 
2014. 13 systematic 
reviews were 
reviewed after 
searching 7 
databases. Search 
criteria: humans, 
English language, 
adult: 19+ yrs, field: 
title and abstract. 
Inclusion: published 
in peer-reviewed 
journals, participants 
had stroke, reported 
a clear objective to 
identify OM specific 
for the UE, report 
psychometric 
properties of the 
OM. 
In 13 reviews, 53 
OMs were 
addressed. FMA, 
ARAT, BBT, 
CAHAI, WMFT, 
MAS, MI, FAT, 
CMSA, NHPT, 
STREAM, 
kinematic measures 
and ABILHAND 
were included. 
AMSTAR-tool was 
used to appraise the 
reviews.  
 
 
6 OMs had a high 
level of measurement 
quality and clinical 
utility: FMA, ARAT, 
BBT, CAHAI, 
WMFT, and 
ABILHAND. Authors 
recommend use of 
these OMs for 
research and clinical 
practice over all other 
OMs reviewed.  
Conclusions were 
based on conclusions 
made by the authors of 
the original systematic 
reviews. Overlap of 
articles used in 
systematic reviews. 
Technology assisted 
OMs were excluded. 
Limited info was 
found from primary 
studies that OMs were 
extracted from.  
 
Abbreviations Key: AMSTAR- Assessment of Multiple Systematic Reviews, MMAC- Modified Motor Assessment Chart, MAS- Motor 
Assessment Scale, MCA- Motor Club Assessment, MI- Motoricity Index, NHPT- Nine Hole Peg Test, OM – outcome measure, RMA- Rivermead 
Motor Assessment, BBT- Box and Block Test, STREAM- Stroke Rehabilitation Assessment Movement, FAT- Frenchay Arm Test, CMSA- 
Chedoke-McMaster Stroke Assessment. 
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Parkinson’s Disease Assessments 
 
Parkinson’s Disease Systematic Review Results 
Author, Year Study 
Objectives 
Study 
Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description Inclusion 
and Exclusion Criteria 
Interventions & 
Outcome 
Measures 
Summary of Results Study Limitations 
Proud, Miller, 
Bilney, 
Balachandran, 
McGinley, & 
Morris (2015) 
1) Identify 
assessments 
appropriate for 
pts with PD that 
measure UE 
impairment, 
activity 
limitation, or 
restriction in 
participation.  
2) Determine 
psychometrics 
and clinical 
utility of the 
measures for pts 
with PD.  
3) Use ICF 
framework to 
compare 
assessments. 
Descriptive, 
systematic 
review; 
Pyramid 
level: D1, 
AOTA level: 
I 
N=18 assessments (7 
PD and movement 
disorder specific tests, 
and 11 for other 
conditions) were 
identified. N=10 
studies that identified 
assessment 
psychometrics. 
Inclusion: knows 
English, Dx of 
idiopathic PD, 
Evaluated tx or 
disease progression, 
quantified UE 
impairment, activity 
limitation, and/or 
participation 
restriction, Described 
test protocol that 
could be replicated,  
provide sufficient 
detail of 
assessment(s), no 
kinematic analyses. 
Assessments 
were identified 
by searching 9 
databases. 
Studies were 
identified by 
searching 5 
databases. 
Checklist 
developed by 
Terwee et al and 
COSMIN 
checklist were 
both used to 
determine quality 
of assessments 
and studies. 
Most assessments 
could be finished 
within 10 min. and 
cost <$100. Only the 
UPRDS requires 
training. Inter-rater 
and intra-rater 
reliability of certain 
UPDRS UE items is 
moderate. Fair support 
for test/re-test, 
reliability of PPT, 
MPS, and CAPIT. No 
high-quality studies 
investigated 
responsiveness or 
validity. Evidence of 
reliability for UPDRS 
and CAPIT, but little 
support for validity 
and responsiveness. 
Little evidence of test-
retest reliability for 
PPT. Moderately 
strong between disease 
severity and PPT 
scores. 
Most studies included 
<25 participants 
(range: 12-411) with 
duration of the disease 
>5 yrs, meaning that 
external validity is 
relatively weak and 
might only apply to pts 
in relatively more 
progressed stages of 
PD. 
Study may lack 
comprehensiveness 
since many timed UE 
assessments excluded 
due to lack of details or 
description in studies, 
or equipment not 
available 
commercially. 
Limited responsiveness 
and validity studies 
could limit the clinical 
utility of the measures 
addressed in this 
review.  
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Abbreviation Key: AOTA – American Occupational Therapy Association, CAPIT – Core Assessment Program for Intracerebral Transplantations, 
COSMIN – consensus-based standards for the selection of health status measurement instruments, Dx – diagnosis, ICF – International 
Classification of Functioning, Disability, and Health, min. – minute(s), MPS – Motor Performance Series, PD – Parkinson’s disease, pts – patients, 
PPT – Purdue Pegboard Test, tx – treatment, UE – upper extremity, UPDRS – Unified Parkinson’s Disease Rating Scale 
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The Rush Dyskinesia Rating Scale Review Results 
 
Author, 
Year 
Study Objectives Study 
Design/ 
Level of 
Evidence 
Participants: 
Sample Size, 
Description Inclusion 
and Exclusion 
Criteria 
Interventions & 
Outcome Measures 
Summary of Results Study Limitations 
Colosimo, 
Martinez-
Martin, 
Fabbrini, 
Hauser, 
Merello, 
Miyasaki, 
Poewe, 
Sampaio, 
Rascol, 
Stebbins, 
Schrag, & 
Goetz 
(2010).  
Compare 
psychometrics of 
assessments that 
measure drug-
induced dyskinesia 
in pts with PD to 
make 
recommendations 
regarding clinical 
utility.  
 
Descriptive, 
systematic 
review; 
Pyramid 
level: D1, 
AOTA 
level: I 
N=8 assessments; 
identified by 
systematic literature 
search and consensus 
among task force 
members following 
the same methods as 
the task forces that 
critiqued rating scales 
for mental health in 
PD.  
Psychometric data was 
summarized and 
clinical utility was 
addressed for each 
measure. Measures 
included AIMS, 
UPDRS, Obeso 
(CAPIT), RDRS, 
CDRS, Lang-Fahn, 
PDYS-26, and 
UDysRS. Researchers 
assigned each 
assessment as either 
“recommended”, 
“suggested”, or 
“listed” depending on 
which of the following 
criteria are met: if it 
has been studied 
clinimetrically and 
found to have sound 
psychometric data, if 
there were studies 
authored by 
individuals not 
involved in the test’s 
development, and if it 
had been applied to 
Only RDRS and 
AIMS received a 
rating of 
“recommended”. Six 
measures were rated 
as “suggested” and no 
measures were rated 
as “listed”. A caveat to 
the rating system: 
some scales rated as 
“suggested” have very 
strong psychometrics, 
however, they were 
too new to position 
them in 
“recommended” 
status. High inter- and 
intra-rater reliability 
for RDRS with good 
clinical utility (e.g., 
time to administer). 
May be difficult to 
tease out specific 
dyskinesia with RDRS 
and does not assess 
disability in the 
context of wide 
variety of functional 
Study lacked 
thorough 
discussion of the 
search strategy, 
especially with 
respect to articles 
or studies 
included in this 
review. Select 
studies could 
have been 
selected to focus 
on strengths and 
minimize 
weaknesses of the 
measures. 
Limited search 
using only 2 
databases to find 
articles.  
Very few specific 
psychometric data 
listed, especially 
for newer 
measures (e.g., 
No discussion of 
MCID or 
sensitivity). This 
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pts with PD.   activities.  can make 
comparing 
measures 
difficult.  
Goetz, 
Stebbins, 
Chung, 
Hauser, 
Miyasaki, 
Nicholas, 
Poewe, 
Seppi, 
Rascol, 
Stacy, Nutt, 
Tanner, 
Urkowitz, 
Jaglin, & 
Ge (2013).  
Objectives of this 
RCT included 
comparing the 
sensitivity of 
measures that 
capture data on 
dyskinesia 
secondary to PD, 
determine effect 
sizes, and to explore 
placebo-related 
immunities.  
Double-
blind 
randomized 
controlled 
trial; 
Pyramid 
level: E2, 
AOTA 
level: I  
N=60 pts statistical 
power was achieved 
at 50).  
Inclusion criteria: Dx 
of PD, Age: 30-90 
yrs, permanent 
dyskinesia (CGI-s 
score >3), 
documented normal 
creatinine level, no tx 
with amantadine >3 
mos., stable doses of 
all antiparkinsonian 
medications for >4 
wks, caregiver 
willing to participate, 
no brain surgery, 
urinary retention, 
glaucoma, 
depression, dementia 
or hallucinations.  
Pts with PD were 
randomly assigned to 
either amantadine or 
placebo treatment 
groups. Pts 
participated for 8 wks. 
One pre- and 2 post-
evaluations were 
administered using 
UDysRS, LF, PDD-
26, RDRS, AIMS, 
dyskinesia items from 
MDS-UPDRS, and 
CGI-C and CGI-S. 
Order in which 
measures were 
administered was 
randomized for each 
visit. Sensitivity to 
change was analyzed 
using a repeated-
measures ANOVA. 
Only four measures 
(CGI-C, LD, PDD-26, 
& UDysRS) were 
sensitive to changes in 
dyskinesia between tx 
and placebo groups; 
not RDRS. Small 
effect size for RDRS 
(0.003) compared to 
UDysRS (0.138). 
UDysRS was most 
sensitive; could detect 
a tx change 80% of 
SD. UDysRS 
combines aspects of 
RDRS and AIMS, 
neither of those latter 
measures could detect 
tx changes 
independently. 
Intraclass correlations 
for UDysRS were 
higher when pts were 
rated face-to-face as 
opposed to video 
camera. No 
assessments were 
immune to placebo 
effects (attributed to 
biochemistry of PD 
and trial design).  
While it was a 
double-blind 
study, measures 
were known to 
raters as they 
were 
administered 
which could have 
resulted in biased 
scoring. 
Placebo group 
had significantly 
higher CGI-S 
scores at baseline. 
The number of 
scales 
administered 
during each visit 
(8) could have 
caused fatigue.   
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Abbreviations Key: AIMS – Abnormal Involuntary Movement Scale, CDRA – Clinical Dyskinesia Rating Scale, CGI-C – Clinical Global 
Impression (change), CGI-S – Clinical Global Impression (severity), MCID – Minimal Clinically Important Difference, Dx – diagnosis, LF – 
Lang-Fahn Activities of Daily Living Dyskinesia Rating Scale, MDS-UPDRS – Movement Disorder Society-sponsored revision of the Unified 
Parkinson’s Disease Rating Scale, PD – Parkinson’s disease, PDD-26 – Parkinson’s Disease Dyskinesia Scale, PDYS-26 – Parkinson Disease 
Dyskinesia Scale, pts – patients, RCT – Randomized Controlled Trial, RDRS – Rush Dyskinesia Rating Scale, SD – standard deviation, tx – 
treatment, UPDRS – Unified Parkinson’s Disease Rating Scale, UDysRS – Unified Dyskinesia Rating Scale, wks – weeks, yrs – years 
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Summary of Findings 
Overall, 33 studies on the psychometric properties of UE assessments for stroke and three for PD 
were identified for inclusion in this appraisal. The studies identified were conducted in limited settings 
and with limited populations. Many articles did not include patients with cognitive impairment, which 
limits the generalizability of the results to clinical populations. Many of the stroke studies also required a 
certain level of motor return to participate, which resulted in less information on suitability of the measure 
for more severely impaired clients.  The studies on PD also lacked diversity in the study populations in 
terms of severity, and little fluctuation or dyskinesia. Within the studies, many of the assessments were 
administered by physical therapists. It is unclear whether there would be any differences related to     
being administered by occupational therapists 
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Table 7 
Summary of Key Finding for Stroke Assessments 
 ARAT AMAT  
Brief 
description 
As outlined by Yozbatiron, Der-Yeghiaian, and Cramer 
(2008), the test consists of 19 tasks split into 4 subscales 
(grasp, grip, pinch, gross motor) and scored on a 4 point 
ordinal scale based on task performance. While other 
authors have suggested changes to the test, we 
recommend following the structure and format outlined 
by the aforementioned authors for consistency in 
administration. 
Measures qualitative and quantitative aspects of 13 ADL that 
each involves 1-3 movements or components. Movements and 
components are performed continuously; therefore, this 
assessment does not interfere with natural movements. Non-
affected UE can be used to stabilize. Each task has a 1-2 minute 
time limit. Patients are rated based on ability to perform tasks and 
quality of movement. 
(O’Dell et al., 2011) 
Actual 
component 
tested/aim of 
measure 
Recovery of UE function and motor status after stroke. Functional UE ability and quality of movement. 
Equipment 
Required 
1. 2 metal tubes (different sizes) 
2. 4 blocks (different sizes) 
3. Cricket ball 
4. Marble 
5. Sharpening stone 
6. Tobacco can/lid 
7. Steel washer 
8. Plastic pitcher 
9. 3 ball bearings (different sizes) 
10. Smoothing iron 
11. Plastic cups 
1. Silverware & plate 
2. Play-doh 
3. Foam sandwich 
4. Mug 
5. Comb 
6. 2 styles of shirts 
7. Towel 
8. Jar 
9. Door 
10. Light switch 
11. Kidney beans 
12. Telephone 
13. Shoe/shoelace 
Test items Grasp subscale: 
1.     Block, 10 cm3 
1.     Cut “Meat” 
2.     Foam “sandwich” 
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2.     Block, 2.5 cm3 
3.     Block, 5 cm3 
4.     Block, 7.5 cm3 
5.     Cricket ball 
6.     Sharpening stone 
Grip subscale: 
7.     Pour water from one glass to another 
8.     Displace 2.25-cm alloy tube from one side of table 
to the other 
9.     Displace 1-cm alloy tube from one side of the table 
to the other 
10.  Put washer over bolt 
Pinch subscale: 
11.  Ball bearing, held between ring finger and thumb 
12.  Marble, held between index finger and thumb 
13.  Ball bearing, held between middle finger and thumb 
14.  Ball bearing, held between index finger and thumb 
15.  Marble, held between ring finger and thumb 
16.  Marble, held between middle finger and thumb 
Gross movement subscale: 
17.  Hand to behind the head 
18.  Hand to top of head 
19.  Hand to mouth 
3.     Eat with spoon 
4.     Drink from mug 
5.     Comb hair 
6.     Open jar 
7.     Tie Shoelace 
8.     Use telephone 
9.     Wipe up spilled water 
10.  Put on cardigan (jacket-style) sweater 
11.  Put on T-shirt 
12.  Prop on extended arm 
13.  Light switch/door 
(Kopp et al, 1997) 
Scoring 0 – Subject unable to complete any part of the task 
1 – Subject partially completes task 
2 – Task completed with great difficulty or takes 
abnormal length of time 
3 – Task performed normally 
Functional Ability Scale: 
1. Does not attempt with involved arm. 
2. Involved arm does not participate functionally; however, 
attempt is made to use the arm. In unilateral tasks that uninvolved 
extremity may be used to move the involved extremity. 
3. Does, but requires assistance of uninvolved extremity for 
minor readjustments or change of position, or requires more than 
two attempts to complete, or accomplishes very slowly. In 
bilateral tasks the involved extremity may serve only as a helper 
or stabilizer. 
4. Does, but movement is influenced to some degree by synergy 
or is performed slowly and/or with effort. 
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5. Does, movement is close to normal*, but slightly slower; may 
lack precision, fine coordination or fluidity. 
6. Does, movement appears to be normal.* 
 
Quality of Movement: 
1. Partial range movement accomplished, but: 
2. Movement dominated by synergy, or there is gross 
incoordination between limb segments, or extremity 
nonfunctional for weight bearing activities. 
3. Movement accomplished, but: 
a. Is influenced by synergy, or is accompanied by excessive 
compensatory movements of trunk, head, or contralateral upper 
extremity, or lacks either proximal control or fine motor ability, 
or movement performed very slowly, or minimally able to 
perform weight bearing activities. 
4. Some isolated movement, but: 
a. Influenced to some degree by synergy, or movement with little 
influence of synergy but performed slowly, or moderate 
incoordination and lack of accuracy, or weight bearing activities 
are performed with difficulty, or primitive grasp patterns are 
present. 
5. Movement close to normal*, but: 
a. Slightly slower, or lacks precision, fluidity or precise 
coordination of movement, or able to perform weight bearing 
activities but with some hesitancy or mild difficulty. 
6. Normal movement*: 
a. Fluid and coordinated activity, speed of movement appears 
within normal limits. 
 
(*) For the determination of normal the uninvolved limb can be 
utilized as an available index for comparison, with premorbid 
limb dominance taken into consideration.ent Scale: 
 
Clinical Utility Cost: Assessment is free, kit components must be 
purchased. 
Cost: $25; 
Time: 30-40 min (31-60 min test); Time to administer is less with 
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Time: 5-15 minutes (10-20 to set up) 
Training: None, recommend following the standardized 
administration outlined by Yozbatiron (Yozbatiron, Der-
Yeghiaian, & Cramer, 2008). 
items removed.   
Training: Reading an article/manual. 
Reliability Interrater reliability: ICC 0.92-0.9986; percentage 
agreement 94% (Nijland, et al., 2010; Yozbatiron, Der-
Yeghiain, & Cramer, 2008) 
Intrarater reliability: ICC 0.97- 0.99; percentage 
agreement 89-91% (Nijland, et al., 2010; Yozbatiron, 
Der-Yeghiain, & Cramer, 2008; Nordin, Murphy, & 
Danielsson, 2014) 
Interrater reliability: 0.95, 0.68-1.0, 0.69-0.99 (Kopp, Kunkel, 
Herta Flor, Platz, Mauritz, Gresser, McCulloch, & Taub, 1997; 
O’Dell, Kim, Finnen, & Polistena, 2011)  
Test-retest reliability: 0.93-0.99 (Kopp, Kunkel, Herta Flor, Platz, 
Mauritz, Gresser, McCulloch, & Taub, 1997) 
ICC: 0.94-0.97 (O’Dell, Kim, Finnen, & Polistena, 2011)  
 
Validity Predictive validity: 0.45 (Chen, Lin, Wu, & Chen, 2012) 
Construct validity: Disordered, moderate with age, 
minimally with stroke severity, moderate with strength, 
poor with light touch, poor with pain, poor with spasticity 
(Chen, Lin, Wu, & Chen, 2012; Lang, Wagner, 
Dromerick, & Edwards, 2006) 
Concurrent validity: 0.82-0.97 (Hsieh, Hsueh, Chiang, & 
Lin, 1998; Nijland, et al., 2010) 
Conflicting results on floor effect: One article found an 
effect at day 14, one found no floor effect (Lin, et al., 
2009; Nijland, et al., 2010) 
Concurrent validity with MI is modest but significant; Significant 
correlations between AMAT-13, FIM self-care scale, and SIS; 
Correlation coefficients with ARAT, FMA, and WMFT: 0.78-
0.79 (O’Dell, Kim, Finnen, & Polistena, 2011; O’Dell, Kim, 
Rivera, Fieo, Christos, Polistena, Fitzgerald, & Gorga, 2013) 
 
 
Internal 
consistency 
Unidimensionality established: Scalability coefficient H 
= 0.79-0.95 (Van der Lee, Roorda, Beckerman, 
Lankhorst, & Bouter, 2002; Koh, et al., 2006)  
Cronbach’s alpha = 0.985 (Nijland, et al., 2010) 
ICC: 0.94- 0.97 (O’Dell, Kim, Finnen, & Polistena, 2011)  
 
Minimal 
clinical 
significant 
difference 
(minimal 
detected 
MCID: 5.7, 10% (this result from a stronger article) (Van 
der Lee, et al., 2001)  
For dominant hand: 12 points, 21% of total, effect size 
0.78 (Lang, Edwards, Birkenmeier, & Dromerick, 2008) 
For non-dominant hand: 17 points, 30% of total, effect 
size 1.10 (Lang, Edwards, Birkenmeier, & Dromerick, 
Differences detected with the passing of one versus two weeks. 
(Rowland & Gustafsson, 2008). 
IDENTIFYING AND IMPLEMENTING ASSESSMENTS      62 
change) 2008) 
Responsiveness Lower than FMA (difference in SRM 0.47); effect size 
0.49-1.390, Wilcoxon test 4.4-4.5 (Hsieh, et al., 2009) 
Responsiveness ranged from not well established to intermediate 
responsiveness. (O’Dell, Kim, Finnen, & Polistena, 2011; O’Dell, 
et al., 2013) 
 
 
Resources Link to test form: 
http://www.strokecenter.org/trials/scales/action_research
_arm_test.pdf 
Recommended administration: 
http://www.ncbi.nlm.nih.gov/pubmed/17704352 
Score sheet and guidelines available at: 
http://www.neuropt.org/docs/edge-documents/stroke-edge-
compendium-of-instructions2A86360E9D57.pdf?sfvrsn=2 
(search for Arm Motor Ability Test) 
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 CAHAI  MESUPES S-WMFT 
Brief 
description 
An assessment composed of 13 
test items that utilize both UE in 
functional activities. Each activity 
is rated on a 7 point scale that 
measures level of independence 
via observation of patient 
performance. Three shortened 
versions of the assessment exist 
which include 7, 8 and 9 tasks.  
(Figueiredo, 2009) 
Newer assessment that measures 
movement performance quality of the 
hemiparetic upper extremity. Seventeen 
items assessment with two subtests for 
arm function: 1) MESUPES-arm (8 items) 
and, 2) MESUPES-hand (9 items). 
(McDermott, 2015) 
 
The streamlined version (Bogard et al., 2009) 
consists of 6 function based tasks ranged from 
less to most difficult, scored on a 6 point ordinal 
scale based on bilateral use and quality of 
movement. Tasks are also timed. There is a 
version of the test for sub-acute stroke and a 
version for chronic stroke. 
Actual 
component 
tested/aim of 
measure 
Recovery of UE function after 
stroke. (Figueiredo, 2009) 
Quality of movement performance post- 
stroke. (McDermott, 2015) 
Characterizes motor status of patients with mild 
to moderate chronic stroke and TBI 
Equipment 
Required 
For CAHAI-9 version: 
1.     Dycem 
2.     200g jar of coffee 
3.     Push button telephone 
4.     12”/30cm ruler 
5.     8.5” x 11” paper 
6.     Pencil 
7.     2.3L plastic pitcher with lid 
8.     250 ml plastic cup 
9.     Wash cloth 
10.  Wash basin (24.5 cm. in 
diameter, height 8 cm.) 
11.  Pull on vest with 5 buttons 
(one side male & one side female) 
12.  Bath towel (65cm X 100cm) 
13.  75 ml toothpastes with screw 
lid, >50% full 
14.  Toothbrush 
1. Mat 
2. Desk 
3. Chair (positioned so patient is 
sitting with hips and knees in 90 
degrees flexion). 
4. Plastic or wooden block (marked 
with 1cm and 2cm to measure 
ROM during hand tasks) 
5. Large plastic bottle (cylinder with 
a diameter of 6cm, such as a 20fl 
oz soda or water bottle) 
6. Small plastic bottle (cylinder, 
diameter 2.5cm, height 8cm) 
7. Dice (1.5 x 1.5 cm) 
(McDermott, 2015) 
1. Chair 
2. Box (25.4cm tall) 
3. Free-weights 
4. Pencil 
5. Paperclip 
6. Can 
7. Table (28cm long) 
8. Bedside table 
9. Cards 
10. Checkers 
11. Basket 
12. Towel 
13. Key lock with key 
14. Dynamometer 
Note: this equipment list is for the full version 
of the test, not the streamlined versions. 
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15.  Dinner plate (Melamine or 
heavy plastic, 25 cm. in diameter) 
16.  Medium resistance putty 
17.  Knife and fork 
18.  Built up handles the length of 
the utensil handle 
Test items 1.     Open jar of coffee 
2.     Call 911 
3.     Draw a line with a ruler 
4.     Pour a glass of water 
5.     Wring out washcloth 
6.     Do up five buttons 
7.     Dry back with towel 
8.     Put toothpaste on toothbrush 
9.     Cut medium resistance putty 
(http://www.cahai.ca) 
MESUPES arm scale: 
1.     Hand to stomach 
2.     Hand back to starting position 
3.     abduction 0°-90°, arm extended, 
forearm in neutral position (arm slides on 
the table) 
4.     Arm back to starting position 
5.     Hand from knee (starting position) 
onto the table 
6.     Hand(palm) to mouth (elbow 
remains on the table) 
7.     Reach for a plastic bottle on the table 
at arm’s length in front of the patient’s 
midline (grasping the bottle is not 
required) 
8.     Hand on top of the head (shoulder in 
abduction) 
MESUPES hand scale: 
1.     Pinch grip 
2.     Wrist extension 
3.     Opposition of thumb and little finger 
4.     Selective extension of 3rd finger 
5.     Starting position with fingers 4 and 5 
slightly spread out; spread index and 
middle finger simultaneously, sliding on 
the table 
6.     Selective extension of 5th finger 
(McDermott, 2015) 
Sub-acute test items: 
1.     Hand to table 
2.     Hand to box 
3.     Reach and Retrieve 
4.     Lift can to mouth 
5.     Lift pencil from table 
6.     Fold towel 
Chronic test items: 
1.     Extend elbow with weight 
2.     Hand to box 
3.     Lift can to mouth 
4.     Lift pencil from table 
5.     Turn key in lock 
6.      Fold towel 
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Scoring These are general scoring 
guidelines. Each task has specific 
guides for scoring as well. 
7 (complete independence) - All 
of the tasks are performed safely, 
without modification, assistive 
devices or aids, and within 
reasonable time. 
6 (modified independence) - 
Activity requires any one or more 
of the following: an assistive 
device, more than reasonable 
time, or there are safety (risk) 
considerations. 
5 (supervision) - The client 
requires no more help than 
standby, cueing or coaxing, 
without physical contact. A helper 
sets up needed items or applies 
orthoses. 
4 (minimal assistance) - With 
physical contact the client 
requires no more than touching, 
and client expends 75% or more 
of the effort. 
3 (moderate assistance) - Weak 
limb manipulates and stabilizes 
during the task. The client 
requires more help than touching, 
or expends more than 50% of the 
effort.  
2 (maximal assistance) - Weak 
limb stabilizes during task. The 
client expends less than 50% of 
the effort, but at least 25%. 
1 (total assistance) - The client 
Passive (scores: 0-1) 
• Patient: Is asked to let the therapist 
perform the movement with the affected 
arm. 
• Therapist: Performs the task slowly to 
evaluate the adaptation of the tone to the 
movement. 
0 = No adequate adaptation of tone to the 
movement (hyper-or hypotonia). 
1 = Adequate adaptation of tone (normal 
tone) to at least part of the movement. 
Assisted (score: 2) 
• Patient: Is asked to help perform the 
movement. 
• Therapist: Assists the patient as much as 
needed to perform the movement 
normally. Feels if and how much the 
patient actively contributes to the 
movement in a normal way. 
2 = Participation through normal muscle 
contraction in at least part of the 
movement. 
By him/herself (scores: 3-5) 
• Patient: Performs the movement without 
help. 
• Therapist: Watches how far the patient 
can move in a normal way. 
3 = Performs part of the whole movement 
normally. 
4 = Completes the whole movement 
normally but performs it slowly or with 
great effort. 
5 = Completes the whole movement 
normally at normal speed. 
(McDermott, 2015) 
0 – Does not attempt with upper extremity (UE) 
being tested. 
1 –UE being tested does not participate 
functionally; however, attempt is made to use 
the UE. In unilateral tasks the UE not being 
tested may be used to move the UE being tested. 
2 – Does, but requires assistance of the UE not 
being tested for minor readjustments or change 
of position, or requires more than two attempts 
to complete, or accomplishes very slowly. In 
bilateral tasks the UE being tested may serve 
only as a helper. 
3 – Does, but movement is influenced to some 
degree by synergy or is performed slowly or 
with effort. 
4 – Does; movement is close to normal *, but 
slightly slower; may lack precision, fine 
coordination or fluidity. 
5 – Does; movement appears to be normal *. 
(*) For the determination of normal, the less-
involved UE can be utilized as an available 
index for comparison, with pre-morbid UE 
dominance taken into consideration.   
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expends less than 25% of the 
effort. (http://www.cahai.ca) 
Clinical 
Utility 
Cost: Assessment is free, but need 
to purchase materials to make kit 
Time: 25 minutes for CAHAI-13 
version 
Training: None required, but a 
training video is available for 
purchase from 
http://www.cahai.ca/. 
Cost: Free 
Time: 10 minutes 
Training: None 
(McDermott, 2015) 
Cost: Free 
Time: Around 10-15 minutes 
Training: None 
Reliability Test-retest reliability: CAHAI-13: 
0.98, CAHAI-9: 0.97, CAHAI-8:  
0.97, CAHAI-7: 0.96. (Barreca, et 
al., 2006) 
Kappa values ranging from 0.63-0.96 to 
0.62-0.79. (Van de Winckel, et al., 2006) 
Kappa-value of >0.86 on 10 out of 17 
items. (Van de Winckel, et al., 2006) 
SEM= 2.68. (Johansson & Häger, 2012) 
ICC of >0.98 for subscores and total 
score. (Johansson & Häger, 2012) 
ICC range 0.37-.74 (Chen, et al., 2012) 
Validity Construct validity (ROC curve): 
CAHAI-13: 0.95, CAHAI-9: 0.94, 
CAHAI-8: 0.93 CAHAI-7: 0.97. 
(Barreca, et al., 2006) 
Correlation score of r = 0.87 for 
MESUPES and the UE part of the M 
MAS. (Johansson & Häger, 2012) 
No differential functioning found: Hierarchy of 
items the same across participants. 
Concurrent validity with FMA good (rho = 
0.58-0.69), with SIS-Hand good (rho = 0.57-
0.59). (Wu, et al., 2011) 
Predictive validity: Significant correlation with 
both FMA and SIS-Hand results post-treatment 
(rho > 0.56, p < 0.01) (Wu, et al., 2011) 
Internal 
consistency 
CAHAI-13: 0.98, CAHAI-9: 0.98, 
CAHAI-8: 0.98, CAHAI-7: 0.97. 
(Barreca, et al., 2006) 
Not addressed Unidimensionality found: 72.2% of variance 
explained by Rasch dimension (Chen, et al., 
2014) 
Minimal 
clinical 
significant 
Not addressed. Minimum detectable change: 18% 
(Johansson & Häger, 2012) 
Not addressed. 
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difference 
(minimal 
detected 
change) 
Responsiven
ess 
Not addressed Not addressed Responsiveness of subacute and chronic 
versions moderate: d = 0.41-0.52 (Wu, et al., 
2011) 
Resources Link to administration manual: 
http://www.cahai.ca 
Link to administration manual: 
http://www.strokengine.ca/wp-
content/uploads/2015/09/SCALE-
MESUPES-English.pdf 
 
Link to administration of full WMFT: 
https://www.google.com/search?q=administerin
g+the+wolf+motor+function+test&ie=utf-
8&oe=utf-8 
Link for streamlined version outline: 
http://www.ncbi.nlm.nih.gov/pubmed/19276293 
 
Abbreviations Key: MESUPES- Motor Evaluation Scale for Upper Extremity in Stroke patients, CAHAI- The Chedoke Arm and Hand Activity 
Inventory, FMA – Fugl-Meyer Assessment, MESUPES - Motor Evaluation Scale for Upper Extremity in Stroke Patients, M MAS – Modified 
Motor Assessment Scale, ROC – receiver operating characteristic, SEM- standard error of the mean, SIS – Stroke Impact Scale, ICC- intraclass 
correlation coefficient, UE- upper extremity. 
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Table 8 
Summary of Key Finding for Parkinson’s Disease Assessments 
 MDS-UPDRS RDRS 
Brief description Developed as a comprehensive, flexible, and efficient means 
keep track of disability as a result of Parkinson’s disease. 
There are 65 items that are measured using an ordinal scale 
of 0-4. 1) “Non-motor experiences of daily living”, 2) 
“Motor experiences of daily living”, 3) “Motor 
examination”, and 4) “Motor complications”.  It combines 
patient report with clinician observations (Movement 
Disorder Society, 2008). 
Patient is observed while drinking from a cup, putting on 
and buttoning a coat, and walking (Colosimo et al., 2010). 
Test has similar items as the Obeso Dyskinesia Rating Scale 
(Colosimo et al., 2010). Uses a rating scale (0-4) with 
descriptors to rate dyskinesia in terms of interference with 
function. In the original version, 3 activities were rated with 
the highest rating was entered as the disability score. Some 
modified versions assign 3 separate scores. Others include 
additional tasks such as communication (Colosimo et al., 
2010). 
Actual component 
tested/aim of 
measure 
Motor impairment and ability to engage in ADL Assess the severity of dyskinesia in functional contexts 
Equipment Required None None 
Clinical Utility Cost: free (must request permission from Movement 
Disorder Society to use) 
Time: 30 minutes 
Training: Strongly recommended (related expenses 
apply) 
Cost: free 
Time: 5 minutes or less 
Training: required, not specified 
Reliability Not established.  Limited reliability data; a study by Goetz et al, 1994 
demonstrated significant inter-rater and intra-rater 
consistency (Raad, 2014).  
 
Validity Concurrent:  
Part I: Excellent (r = 0.76) 
Not established.  
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Part II: Excellent (r = 0.92) 
Part III: Excellent (r = 0.96) 
Part IV: Excellent (r = 0.89) 
(Raad, 2016) 
Internal consistency Part I: Adequate (α = 0.79) 
Part II: Excellent (α = 0.90) 
Part III: Excellent (α = 0.93) 
Part IV: Adequate (α = 0.79) 
(Raad, 2016) 
Not established. 
Minimal clinical 
significant difference 
(minimal detected 
change) 
Part I: Adequate (lowest 0.1%/highest 0.8%) 
Part II: Adequate (lowest 0.1%/highest 0.7%) 
Part III: Adequate (lowest 0.1%/highest 0.2%) 
Part IV: Poor (floor effect but no ceiling effect) 
(Raad, 2016) 
Not established.  
Responsiveness Not established.  Poor; P = 0.621, effect size = 0.003 
(Raad, 2014; Goetz et al., 2013) 
Resources Link to administration manual: 
http://www.movementdisorders.org/MDS-
Files1/PDFs/MDS-UPDRS_English_FINAL.pdf 
 
Abbreviation Key: ADL - activities of daily living, ICC - intraclass correlation coefficient, MDS-UPDRS - Movement Disorder Society Unified 
Parkinson’s Disease Rating Scale 
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ANALYSIS OF FINDINGS 
Analysis of Stroke Findings 
A search of two online databases resulted in five assessments that were suitable for assessing 
upper extremity voluntary motor control post-stroke and that fit the clinical utility requirements of the 
clinicians. Of the five included assessments, only the AMAT and the CAHAI are comprised of functional 
tasks. During our second meeting with the clinicians regarding the five assessments, they all agreed that 
they preferred the idea of using an assessment that involved functional tasks. The inclusion of functional 
tasks within the AMAT and the CAHAI makes the results more generalizable to measuring participation 
in meaningful activities and is more aligned with occupational therapy practice. The use of functional 
tasks is also shown to improve motor performance in clients post-stroke (Preissner, 2010). The structure 
and scoring of both the AMAT and CAHAI allow for skilled observations to occur during administration 
of the assessments (O’Dell et al., 2011; Barreca et al., 2004). Assessment and observation of functional 
tasks has the potential to provide occupational therapy clinicians with the most generalizable and useful 
data for creating and implementing treatment plans to address voluntary motor control and participation in 
valued occupations. The AMAT and CAHAI also have very strong validity, reliability, and sensitivity 
data to support their use with clients who have mild-to-severe physical impairments (See Table 7).  
Other assessments included in this appraisal were the S-WMFT, ARAT, and MESUPES. The S-
WMFT consists of a combination of functional tasks and isolated movements. The authors of this review 
do not recommend its use with clients who have more severe impairments following stroke due to the 
absence of research with that population. While the S-WMFT is very quick to administer, the limitation in 
populations studied make it less useful for the collaborating skilled nursing facility rehabilitation center 
as, generally, they provide treatment to more severely impaired patients. The psychometric data including 
validity, reliability, and sensitivity for the S-WMFT is just average (See Table 7). The ARAT and 
MESUPES both consist solely of isolated movement tasks, which is less applicable to function in 
ADL/IADL and does not address the concerns of the collaborating clinicians. The ARAT does have 
strong reliability, moderate predictive validity, strong concurrent validity, and variable-strength construct 
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validity (See Table 7). Additionally, the minimal clinically important difference (MCID) of the ARAT is 
good, falling between 10 and 30% (See Table 7). However, the strict inclusion and exclusion criteria of 
the ARAT-related studies, the lack of data on its application with more severe stroke patients, and the 
lengthy set-up time of the ARAT demonstrates low generalizability and low clinical utility, both of which 
outweigh its potential strengths. The MESUPES measures the quality of upper extremity movement, 
which is valuable to the clinicians. The psychometric data including reliability and validity is also strong; 
however, there is limited research and psychometric data available to make accurate comparisons with 
other assessments. For example, the MESUPES-related studies included in this appraisal did not 
investigate the sensitivity of the assessment (See Table 7).  
The psychometric data found for all five assessments ranged from moderate to good. However, 
MCID and responsiveness data was not available for all the assessments, and future research should focus 
on filling the gaps in data. Taking the factors of each assessment into consideration, the authors of this 
CAT recommend that the collaborating clinicians utilize the CAHAI-9 with their clients who have 
experienced a stroke. This assessment is comprised solely of functional tasks and is appropriate for a wide 
range of impairment levels post-stroke. In addition, the CAHAI-9 fits the clinicians’ preferences for an 
upper extremity assessment. It is under $300 to assemble the kit, it takes less than 30 minutes to 
administer and score, and it measures voluntary motor control within the contexts of functional tasks. 
Analysis of PD Findings 
A search of the current research on upper extremity function in patients with PD resulted in a 
recent systematic review that the authors of this CAT were able to use as a basis for our search.  Utilizing 
the pragmatic parameters identified by the clinicians, two specific measures were identified that met their 
needs. The Rush Dyskinesia Rating Scale (RDRS) and Movement Disorder Society’s Unified Parkinson’s 
Disease Rating Scale (MDS-UPDRS) both consider the impact of dyskinesia on performing functional 
tasks. Occupational therapy clinicians who use either of the two assessments are able to determine how 
client factors or performance skills impact a client’s participation and performance in occupations. As 
with stroke, considering only components of movement out of context does not always provide clinicians 
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with enough information to understand a client’s participation in occupation or identify functional 
outcomes of the therapy. The Rush Dyskinesia Rating Scale (RDRS) involves only three functional tasks, 
limiting generalizability to other ADL/IADL tasks. Conversely, the MDS-UPDRS provides clinicians 
with a more comprehensive view of client function and limitations. Both assessments are quick to 
administer and are available for free, though there is an associated cost with respect to the training that is 
necessary for competently administering either. The clinicians would benefit most from using the MDS-
UPDRS, because it provides more information regarding client performance. The MDS-UPDRS was 
found to have very strong validity as well (See Table 8). It is important to note that very little or no 
psychometric data was available for the RDRS, which made analysis between the two assessments 
difficult (See Table 8). It is recommended that the RDRS be researched further before being administered 
to clients. For clients with PD, the authors of this CAT recommend using the MDS-UPDRS. The MDS-
UPDRS is more comprehensive, as it allows for a more complete assessment of the functional limitations 
of persons with PD.   
Overall Summary 
This critical appraisal of the topic provided an in-depth analysis of the research to determine 
measures of UE functional use that best meet the needs of occupational therapists who practice within a 
skilled nursing facility. The CAHAI-9 and the MDS-UPDRS are both measures that have strong 
psychometric properties that support their use. The psychometric data that is available for both 
assessments indicate that they are highly valid, reliable, and sensitive for measuring upper extremity 
voluntary motor control in patients with mild to severe impairments as a result of either stroke or PD. 
Additionally, the two identified assessments meet the specific needs of the clinicians in terms of cost, 
time required to administer and score, and ability to measure motor control in the context of function.   
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IMPLICATIONS 
Consumers 
The target population for this review is older adults in a skilled nursing facility who are post-
stroke or with PD. This review reveals that there are assessments available that can be administered in 
less than 30 minutes, cost less than $300, and can be used to set therapy baselines and track progress. 
Ideally, it would be beneficial for a therapist to choose an assessment that is the best fit for the individual 
client. Consumers can use this review to see a summary of the research available on five assessments used 
for stroke and two for PD. They can also be more aware of what specifically is being measured by these 
assessments and the available data on reliability, validity, and other psychometric data. They can know 
that the intervention and treatment being provided by their therapist is rooted in research-driven data, and 
is sensitive to changes in their performance and function. The findings of this paper can also be used to 
justify the continuation of services by demonstrating to insurance companies and other providers that 
gains have been made or that the potential for functional gains is present. 
Practitioners 
Standardized measures are an important part of the occupational therapy process in that they 
provide information on functional impairments for intervention planning and help to quantify outcomes.  
Therapists will need to use clinical reasoning to determine which assessment is best suited to a particular 
population, diagnosis or stage of diagnosis (such as acute, subacute, or chronic), and level of functional 
impairment. For this, clinicians need reliable and valid measures. Practicing therapists can use the data in 
this CAT to make informed choices on which of the various assessments is a best fit for their client.  Not 
all of the assessments included in this study have established minimal clinically important differences 
(MCID), which can affect a clinician’s decision on whether an assessment will be useful beyond the 
initial evaluation. Clinicians should be certain that the assessments they are using can accurately and 
reliably track the changes that make a functional difference to their clients. Lower or unestablished MCID 
must be taken into consideration when interpreting the results of any reassessments, as it would be 
unclear what amount of change is important to the client or clinically significant. All of the assessments 
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included were screened to fit within the existing structure of the facility, and should not require any 
changes to the existing rehabilitation framework or program. 
Researchers 
Critical appraisals are useful for researchers to see the current state of research on a specific topic. In 
addition, appraisals can be used to guide or provide direction on future research. In general, all of the 
assessments mentioned in this review could benefit from further refinement. For example, some 
assessments would benefit from adopting interval scoring as opposed to ordinal scoring in order to 
improve the ease of researching psychometric data for the assessments. Some of the newer assessments 
need more studies that evaluate the psychometric properties and the publication of detailed standardized 
administration guidelines in order to ensure high reliability and promote easy access of information for 
clinicians. Minimum detectable change is a very important piece of psychometric data that all 
assessments should have, thus research should be done to ensure that data is available for each of these 
assessments. There are far fewer high quality studies on assessments for voluntary motor control with PD. 
More research on these assessments would benefit clinicians who work with that population. In particular, 
the Parkinson’s assessments could use further review in order to determine validity and responsiveness. 
All of the assessments would benefit from further research conducted on populations with a wider variety 
of ages and levels of impairments. Qualitative studies that address the concerns of therapists and or the 
experience of the clients when utilizing these measures may also provide valuable information that would 
improve the clinical utility and acceptability of the measures.  
Involvement Plan 
The occupational therapists at Cottesmore of Life Care, a skilled nursing facility in Gig Harbor, 
WA, treat numerous clients who are status post stroke or who have been diagnosed with PD.  The 
clinicians wanted a new measure of upper extremity functional use or abilities that could be used with 
these populations to provide information on initial level of function and track gains made throughout 
treatment. The authors of this CAT narrowed down the available outcome measures based on the clinical 
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utility requirements of the collaborating clinicians and provided in depth information on five assessments 
for stroke and two for PD.  
Developing an Involvement Plan 
 To develop an involvement plan that would meet the needs of the collaborating clinicians, the 
authors of this CAT met with them to discuss our results and to elicit their input on what knowledge 
translation activities would meet their needs. When the authors of this CAT initially presented our 
findings to the collaborating clinicians, they liked the functional tasks that formed part of the Motor 
Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES), as they felt that the tasks 
represented an accurate assessment of motor control return. This initial interest may have come from the 
fact that, no list of tasks for the other assessments was provided to allow for comparison. In future 
meetings, the authors of this CAT made sure to include a list of task items for all assessments. The 
collaborating clinicians felt that the tasks represented an accurate assessment of motor control return.  
They were concerned that the Chedoke Arm and Hand Activity Index (CAHAI) would not accurately 
assess function in clients with more severe stroke, and would not be sensitive enough to track changes. In 
subsequent meetings, the authors of this CAT addressed that concern by explaining that a large portion of 
the research on the CAHAI has demonstrated it is appropriate for use with patients who have moderate to 
severe impairments post-stroke. We described the tasks and task objects that the CAHAI encompasses, 
explaining that many of the tasks within the assessment can be performed bilaterally. Even individuals 
with severe hemiparesis, for example, should be able to experience some degree of success. After this 
concern was addressed, the clinicians agreed that the CAHAI was a good fit for their setting and 
populations.  
The authors of this CAT informed the clinicians that finding research on assessments that 
measure upper extremity functional use for patients with Parkinson’s disease had been more challenging. 
We recommended the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS), mainly due to the comprehensive information that could be derived from its administration. 
One of the clinicians at the SNF reported that patients who have Parkinson’s disease are not referred to 
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occupational therapy at their clinic unless it is a secondary condition that impacts a primary condition. 
There was some miscommunication early on in the process between the collaborating clinicians and 
authors of this CAT regarding the facility’s client population and needs. It was unknown whether they 
will consider implementing an assessment specifically designed for use with Parkinson’s disease as we 
recommended. We noted in our brochure that the MDS-UPDRS is a useful assessment for all aspects of 
PD, that it is used to help assess ADL, mentation, and PD symptoms, and can be used to track clients’ 
progress over time. 
The authors of this CAT informed the clinicians that the next phase of the project is the 
implementation phase and that there are several ways that we could proceed. We created time for the 
clinicians to see the assessments and hear explicitly how they are scored, which may increase the 
likelihood that the assessment will be adopted. Reading a manual or brochure does not convey the 
complexity of administering these measures or opportunities for skilled observation provided by the 
demonstration of the CAHAI. An interactive learning session may also reduce some of the barriers to 
future use by the clinicians.  While it was not feasible to create a test kit for the facility, we provided very 
detailed instructions on how a kit is created (see Appendix D), a cost estimate for creating the kit, and 
then showed the clinicians a completed kit. Providing this information may increase the chance of the 
facility creating and using a kit for the assessment. The clinicians were most interested in having us bring 
the CAHAI and demonstrate its administration on either one of them or on one of their clients. We 
provided the clinicians with a cost estimate for assembling the kit. To help the clinicians determine if they 
would like to proceed with adoption of an assessment for patients with Parkinson’s disease, we also 
agreed to continue to research the MDS-UPDRS. We provided the clinicians with a brochure that outlined 
where they could obtain the manual and the necessary training. It was anticipated that this brochure would 
also help the clinicians to understand how the MDS-UPDRS is applicable to their population and provides 
valuable information on various aspects of PD. At the end of our meeting, the clinicians planned to read 
and share the custom table provided to them so that they could learn more about each of the assessments 
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included in our CAT. Providing our table in a more reader-friendly format such as a booklet also formed 
part of the involvement plan. 
Potential Barriers to Knowledge Translation 
The clinicians were enthusiastic about adopting use of the CAHAI. Possible barriers to 
implementation that we anticipated include a lack of time dedicated to learning the new assessment or a 
lack of administrative support for change. Given the high productivity requirements of this facility, it 
could be very difficult to get the OTR and OTA staff together to provide education on a new or unfamiliar 
assessment, or to make time to problem solve any future concerns or issues that arise in regards to the 
assessment. Other members of the rehabilitation team may not see the value of the new assessment or 
how it will enhance overall service provision.  On a personal level, a clinician who does not agree with 
our recommendation may be much more reluctant to learn and administer the assessment with their 
clients, or may see it as less valuable than other assessments and choose to allocate time in other ways 
than becoming familiar with the measure. Such attitudinal and systemic barriers can be addressed by 
identifying the root of the resistance to change with surveys or more informal methods such as 
conversations (McCluskey, 2013). The authors of this CAT used the in-service as a way to address 
potential barriers in the rehabilitation staff by providing information on the administration and adoption of 
the measures, and answering questions about its use. The involvement of the rehabilitation director in the 
process also reduced potential systemic barriers such as allocation of time for implementation. 
Considering the enthusiasm demonstrated throughout the knowledge translation process to adopt 
use of the CAHAI and the fact that our group carefully selected assessments based on clinical utility 
factors addressed by the clinicians such as time and cost to administer, the only barriers to implementing a 
new assessment should be the time required to learn and practice administering the assessment, creating 
and maintaining the test kit, and providing educational information to future clinicians. However, there 
are many more barriers that could prevent the clinicians from adopting the use of the MDS-UPDRS. The 
clinicians do not currently recognize the value of using the MDS-UPDRS, likely as a result of the limited 
information that we provided them. Limited knowledge of the MDS-UPDRS, potential mismatch with the 
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clinicians’ needs (such as not treating PD as a primary diagnosis or not fitting with their perceived 
evaluation needs), and time are all potential barriers to adopting use of the assessment.  
The Involvement Plan 
Knowledge translation involves the process of taking evidence and implementing it in clinical 
care with clients. Occupational therapists and other health care professionals are expected to provide care 
guided by best practices to which knowledge translation is closely tied. This critical appraisal of a topic 
(CAT) provided a more in-depth analysis of the psychometric properties of each assessment as they were 
administered to specific populations. It is important to consider how different assessments may be more 
or less appropriate for particular client populations. For example, the sensitivity of some assessments may 
differ depending on the severity of a person’s health complications. By working directly with practicing 
clinicians and addressing the specific needs of their facility, the authors of this CAT were able to bridge 
the gap between the published research and implementation of a new assessment. 
The first step of translating knowledge into practice was to present our findings to the clinicians 
in a way that is easily readable and understandable, and that clearly links our findings to their needs. We 
presented the clinicians with an electronic copy of our full paper, printed summaries of our findings 
(Tables 7 & 8), and the implications of our findings on various audiences.  The abbreviated printed 
version reduced the amount of reading necessary to understand the main points of this appraisal, while the 
full electronic version provided them with access to the in-depth research behind our recommendations.   
The second stage of translation involved the creation of two fliers to present to the clinicians.  
One of these fliers highlighted the strengths of the Chedoke Arm and Hand Activity Index, 9-item version 
(CAHAI-9), which was our recommendation for use with clients who are post-stroke.  The flier (see 
Appendix B) is a brief summary of the information provided in our paper and in the administration 
manual for the assessment. We also printed and bound a copy of the administration manual to present to 
the facility with a list of estimated costs to create their own test kit. The second flier (see Appendix C) 
provided information on our recommendation for clients with Parkinson’s disease (PD). This flier focused 
more on general information about the assessment, and included much more information on how to 
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acquire the assessment. Because the clinicians seemed less inclined to adopt an assessment designed 
specifically for PD at their facility, the flier also contained information on the merits of treating PD as a 
primary diagnosis and on collecting data on occupational therapy for upper extremity motor control. Such 
data collection could help to reduce the shortage of information available in this field. 
In order to help the clinicians better understand and feel comfortable and confident with the 
CAHAI-9, we presented the assessment as an in-service. One of the authors of this CAT administered the 
assessment on a second author. The person simulating the client demonstrated various levels of 
impairment and the clinicians discussed and scored the performance according to the guidelines in the 
administration manual. By having the clinicians score a ‘client’ while we were there, we were able to 
determine if they are having difficulty scoring the measure and clarified administration procedures as 
needed. At this time, the authors of this CAT presented them with both fliers, the test manual, and the list 
of items and costs. We brought a completed test kit from the University of Puget Sound as an example, 
and used this to demonstrate the administration of the assessment.  Three test items were demonstrated, 
and were then scored collaboratively.  This collaborative scoring process gave the clinicians a chance to 
be involved in the process, to talk over the scoring guidelines and ask questions about specific movements 
or cuing. Following the in-service, the authors of this CAT led the clinicians in a discussion of the relative 
strengths and weaknesses of the assessment, and talked over potential opportunities and barriers to 
implementing it in their facility.  Responses to the strengths, weaknesses, opportunities, and threats 
(SWOT) analysis were recorded by the students. The steps taken to complete this involvement plan are 
outlined in Table 9. 
Table 9 
Tasks, Dates, and Steps Involved in Implementation Plan 
Task/Product Deadline 
Date 
Completion 
Date 
Steps to achieve the final outcome 
Send an email to the rehabilitation 
director explicitly stating that our 
paper will be undergoing revisions 
3/16/2016 3/16/2016 1. Review task objects for the 
Chedoke and check prices in 
the community. 
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over the duration of the 
implementation phase. This email will 
also outline our implementation plan 
and confirm that they are interested in 
having us put a kit together with a total 
cost estimate. 
2. Decide who will write the 
email. 
3. Write and send the email. 
Provide copy of our summary table 
and implications 
3/26/2016 3/26/2016 1. Provide summary of findings 
2. Provide summary of 
implications of results 
Create a flier about how to find manual 
and set-up a test kit for CAHAI-9 
4/1/2016 4/1/2016 1. Find links to manual and test 
items needed for the kit. 
2. Create and print the flier. 
Create a brochure with information on 
training resources and more in-depth 
information about the MDS-UPDRS 
4/5/2016 4/5/2016 1. Continue to research UPDRS 
to be sure the assessment 
meets the clinicians’ needs and 
find links to training resources 
and manual.  
2. Design and print the brochure. 
Create administration manual 4/11/2016 4/11/2016 1. Create binder with test creation 
info, administration manual, 
and instructions for making 
test items per guidelines 
2. Use manual in demonstration 
and leave with the clinicians as 
additional resource 
Take CAHAI-9 test kit and 
demonstrate administration of test 
4/14/2016 4/21/2016 1. Practice administering the 
Chedoke. 
2. Arrange a time to present to 
clinicians.  
3. Demonstrate the Chedoke on 
one of the researchers 
4. Grade the Chedoke 
collaboratively with the 
clinicians 
5. Respond to questions that 
arose in the demonstration 
Analyze CAHAI-9 with clinicians 4/14/2016 4/21/2016 1. Use SWOT form to identify 
strengths, weaknesses, 
opportunities, and barriers 
Follow-up with clinicians 4/19/2016 4/26/2016 1. Send survey to clinicians to 
ask if any thoughts/concerns 
came up after the presentation 
2. Ask if there is any further help 
we can provide given our 
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timeline 
3. Ask them to think about 
possible research topics for 
next year 
 
Monitoring Outcomes of Knowledge Translation 
The outcomes of the above activities were monitored by having the clinicians provide feedback 
on how helpful each activity was for them. Throughout the in-service, we asked for feedback on the 
assessment and the administration process. We used SWOT analysis with the clinicians after completion 
of the in-service to further identify specific concerns or strengths they identified during the demonstration 
and grading.  Some questions were pre-identified, but the discussion flowed from their thoughts and 
comments. At the time of the in-service, we reminded them of the opportunity for future collaboration 
with students from the University of Puget Sound on similar research topics. Additionally, a survey was 
sent to the facility after the in-service asking how useful the in-service was, if any additional questions 
have come up, and to check if any further assistance could be provided at this time. A copy of the survey 
is included in Appendix E.  
Products Created 
 The clinicians were provided with a brochure covering a general overview of the CAHAI 
(Appendix B). A more comprehensive brochure on the MDS-UPDRS was also provided (Appendix C), 
which gave an outline of the measure, its psychometric data, and arguments in favor of its use. Other 
documents provided to the clinicians included a copy of our summary tables (Tables 7 & 8), implications 
from the CAT, and a bound copy of the CAHAI administration manual. A list of items (see Appendix A) 
needed for the assessment and projected costs was also included in the copy of the administration manual.  
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Effectiveness of the Tasks and Products 
Effectiveness of the In-Service 
On April 21st, 2016, the authors of this CAT visited the clinicians at Cottesmore for a third time. 
We feel that this meeting went well and that the clinicians were very receptive to our ideas. During this 
meeting, we performed a demonstration of three task items of the Chedoke Arm and Hand Activity 
Inventory (CAHAI). We then scored the assessment with the clinicians and talked over questions 
regarding scoring. One clinician had some concerns about the scoring and we were able to answer her 
questions and help her feel more comfortable about the scoring. This interactive way of teaching the 
clinicians about the CAHAI was effective because it gave them an opportunity to ask us questions in the 
moment regarding administration and scoring. By the conclusion of the activity, the clinicians seemed to 
have a clear understanding of how the scoring and administration works and many of their concerns were 
addressed.  
After concluding the demonstration, we went over the assessment with the clinicians and 
performed a SWOT analysis (see Appendix A). The SWOT analysis revealed that the clinicians like the 
functional, relevant nature of the tasks, and that the familiar nature of the tasks will help to address 
concerns about cognition. Most clients will have a habitual response to tasks like dialing a phone or 
cutting food, and will be more able to complete a familiar task than a novel one. The clinicians also 
identified the robust research and wide variety of stroke severity in the populations studied as a strength. 
The clinicians were concerned that use of the assessment might not be compatible with quantifying 
patients’ severity of impairment for Medicare G-codes, which they use frequently. They also had 
questions about the bilateral nature of the tasks, when some clients may be more familiar performing 
them one-handed. We addressed this by reiterating that the test asks clients to perform tasks bilaterally, 
and included cuing for this in the administration instructions. The clinicians were also concerned that 
there would be a big learning curve for this assessment, and that it might be difficult to get all of the 
therapists and therapy assistants feeling competent on administration. The CAHAI has excellent inter-
rater reliability, but some sort of standardization will be necessary within the facility. The clinicians felt 
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that the assessment would track changes in patients’ functional level adequately and that its sensitivity 
would increase as a clinician developed a relationship and built trust with his or her client. The clinicians 
mentioned that even if this assessment was not included on the initial evaluation, it would provide 
valuable information for treatment.  
Effectiveness of the CAHAI Brochure 
A brochure giving a brief overview of the assessment was provided to the clinicians, which 
reiterated some of the key strengths of the assessment that led to our recommendation for its use. The 
clinicians were receptive to the information and felt that it would be beneficial to provide this to therapists 
who were unable to attend the in-service and to clinicians who are hired at the facility in the future. The 
brochure would be given alongside more in-depth training on the use of the CAHAI. 
Effectiveness of the MDS-UPDRS Brochure 
The authors of this CAT also presented the clinicians with a brochure about the MDS-UPDRS 
and its merits. The brochure gave a brief overview of the assessment and a summary of the psychometric 
data. It also covered the value of using diagnosis-specific assessments and recommended the adoption of 
the MDS-UPDRS for use with their clients with PD. The clinicians were initially hesitant about adoption 
of an assessment for PD, but responded positively to the brochure and seemed to better see the value of 
implementation. 
Analysis of In-service 
Overall, the meeting went well and ended on a positive note. The clinicians all agreed that they 
would have to take some time to work out the details of administering the CAHAI-9 with their patients, 
but as a whole they were in agreement that they would like to start utilizing it in their clinic. The 
rehabilitation director told the other clinicians that she would like to set up a meeting with them soon to 
discuss it further and take the next steps necessary to use the assessment in their clinic.  
Results of Follow-Up Survey 
 When asked how likely they were to implement the assessments in their facility, the clinicians 
rated the CAHAI an 8/10 and the MDS-UPDRS a 7/10, indicating that it is likely that they will implement 
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them. They indicated that the assessment was very informative and that the research regarding the 
assessments was ‘extremely useful’ to their setting. When asked, the clinicians did not have any 
suggestions for how the research and process of knowledge translation could be improved upon and they 
indicated that the process utilized was efficient and helpful. 
The authors of this CAT feel that the products and tasks we completed for our research project 
and presented to the clinicians were effective in portraying our results in a concise and timely manner.  
Analysis of the Overall Process 
In September, 2015, we were assigned to work with Nan, who is an occupational therapist and the 
rehabilitation manager at Cottesmore of Life Care skilled nursing facility in Gig Harbor, WA. Through 
meeting with the occupational therapists at Cottesmore, we collectively chose a topic to research and 
commenced our evidence-based research journey.  
Beginning the process was difficult, as we were unsure how best to approach the topic without 
being overwhelmed with information. We had no idea that the scope of the assigned topic would be so 
large, and found it very hard to develop a starting point for all of the information available. Our project 
chair provided valuable insight in how to first narrow the number of assessments, then look only at those 
specific assessments. 
When we initially began searching for articles, it was difficult to keep track of all the articles and 
categorize them into why we did not want to utilize certain articles in our CAT table. After creating our 
CAT table, we analyzed our findings and made conclusions. It was difficult to compare results given that 
each article covered different pieces of psychometric data. However, we tried as best we could to piece 
the information together to understand which assessments had higher psychometric data and why. As we 
began to write the analysis of findings, implications and conclusion, we found it difficult to not become 
redundant with the information we presented. 
Once we had a rough draft of our paper, we met again with the clinicians at the SNF. This 
meeting was helpful because we were able to present our findings and ensure that they had an interest in 
some of the assessments we were analyzing. It was a good chance for them to ask us questions and for us 
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to further understand what their priorities were for an assessment. During this meeting we did feel a bit 
unprepared, as we had spent so much time finding data that our analyses were very primitive.  
The biggest challenge overall of this process was that we were required to search for assessments 
for two separate populations. This made the scope of our paper rather large and entailed developing two 
separate search strategies due to the lack of overlap between the two populations. Addressing two 
populations created challenges related to formatting our paper in an organized manner as well. 
Though we encountered many challenges with the process of researching and writing the paper, 
our final meeting with the clinicians went very well. They were impressed with our knowledge and 
amount of research. They were sincerely interested in using the assessments we recommended in their 
clinic. The rehabilitation director said that she would meet with her team later on to further discuss the 
implementation of the assessment in their clinic. Hearing the clinician’s positive feedback and excitement 
with our findings was very encouraging and made us feel empowered as future clinicians and as research 
analysts. 
Recommendations for Follow-Up Projects 
During our initial meeting, the clinicians suggested numerous topics and questions for further 
research. One of the ideas initially suggested involved research on effective home exercise programs. 
They would like to come up with the most appropriate home exercise program to send home with their 
patients.  
Future research within the topic of upper extremity (UE) assessments could include researching 
all available UE assessments for clients with stroke and comparing the assessments against each other. 
Each assessment could be ranked by cost, time to administer and psychometric data. This sort of research 
would provide clinicians with a good overview of all available assessments and allow them to choose an 
assessment to use based on their specific set of criteria.  
Further research can also be done to determine potential upper extremity PD-specific assessments 
used within occupational therapy. There are currently very few PD assessments that are appropriate for 
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use in OT. Of those that are available, little research has been reported on their psychometric properties 
and the value that these assessments provide to the OT process. 
CONCLUSION 
The occupational therapy clinicians at the skilled nursing facility with whom the authors of this 
CAT collaborated currently use the Modified Barthel Index for clients with stroke and PD, but find the 
measure to be inadequately sensitive to changes in voluntary motor control in the upper extremities. The 
authors of this critical appraisal of the topic assisted the clinicians in identifying appropriate reliable, 
valid, and sensitive assessments based on analysis of the evidence with consideration of the practicality of 
administering each of the measurement tools within the preexisting framework of the facility. A critical 
appraisal of the topic was necessary to ethically and efficiently initiate the knowledge translation process 
on behalf of these working clinicians.  
There are many upper extremity voluntary motor control assessments available for use by 
occupational therapists. Of the assessments available, five assessments for stroke and two assessments for 
PD were found that fit the clinical utility needs of the clinicians. All of the stroke assessments had robust 
psychometric data of a high enough quality to be beneficial to the clinicians at a skilled nursing facility 
rehabilitation clinic. Less data was available for the PD assessments: only four assessments had reliability 
data and only one had validity data. 
Based on these findings, the authors recommend the use of the CAHAI-9 with patients who are 
post-stroke. For PD, we recommend the MDS-UPDRS. However, the authors of this CAT emphasize that 
therapists must use clinical reasoning to determine if a given assessment will be the best fit for their 
clients. With clients post stroke, the severity and presence of comorbidities may affect the results of the 
assessment, and psychometric data may not be as strong for some populations as for others. For PD, the 
lack of information available and the need for clinician training are the biggest drawbacks to the 
assessments included. Further research on upper extremity function in PD would benefit the profession 
and increase the strength of all available assessments. 
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Knowledge translation is a complex process that requires more than reading peer-reviewed 
journal articles (Metzler & Metz, 2010). Possible barriers to the implementation of research knowledge 
into practice include the large volume of research literature available and the often difficult process of 
critically evaluating the evidence (Metzler & Metz, 2010). Rehabilitation professionals face many 
obstacles to knowledge translation that are unique to their niche in healthcare. For instance, rehabilitation 
practice would benefit from evidence derived from case studies to randomized controlled trials and every 
type in between, meaning a therapist could more readily find evidence from a study that lacks rigor. 
Additionally, there may be more opportunities for a therapist to misinterpret or incorrectly apply an 
intervention because there are often specific conditions, such as the intensity and frequency in which an 
intervention was applied, of the protocol used in studies (Metzler & Metz, 2010). Likewise, the sample 
characteristics such as socioeconomic status, culture, and impairment level may differ from the 
population treated by a therapist. Finally, rehabilitation clinicians do not always have the same resources 
available to them that are used by researchers (Metzler & Metz, 2010). One of the aims by the authors of 
this critical appraisal of the topic was to streamline this complex process for the collaborating clinicians 
so that the likelihood of adopting and using more appropriate and sensitive assessments would increase. 
The findings of this study may be extrapolated to other clinicians who work in skilled nursing facilities 
that serve a similar client population.  
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Appendix A 
Analysis of strengths, weaknesses, opportunities and threats to implementing the Chedoke Arm and Hand 
Activity Inventory in the skilled nursing facility 
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Appendix B 
Brochure on the Chedoke Arm and Hand Activity Inventory (CAHAI) 
Chedoke Arm and Hand Activity Inventory (CAHAI) 
-An assessment of bilateral UE use in post-STROKE patients- 
 
The CAHAI assessment has four versions: the 7, 8, 9 and 13 task item versions. The 9-
item version is recommended due to high psychometric data and length of administration time. 
The assessment consists of various occupation based tasks such as using the phone, opening a 
jar, and buttoning a shirt. The assessment is used to measure bilateral UE use and is also a good 
indicator of cognitive functioning.  
 
Facts: 
• Administration time: ~30 minutes 
• Assessment is free- just need to assemble a kit 
• Population: Any patient post- STROKE 
• Developed by OT’s (contact info available) 
• High psychometric data 
• Available online at www.cahai.ca 
 
Tasks for (9-item version) 
• Open jar of coffee 
• Call 911 
• Draw line with a ruler 
• Pour a glass of water 
• Wring out a washcloth 
• Do up five buttons 
• Dry back with towel 
• Put toothpaste on toothbrush 
• Cut putty 
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Appendix C 
Brochure on the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale 
Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale  
(MDS-UPDRS) 
-An assessment of UE use in patients with Parkinson’s Disease- 
 
The MDS-UPDRS was published in 2008. It was designed to address weaknesses, ambiguities, 
and areas in need of inclusion, based on research evidence, of the original UPDRS. There are 
four parts that include: 1) “Non-motor experiences of daily living”, 2) “Motor experiences of 
daily living”, 3) “Motor examination”, and 4) “Motor complications”. There are 65 items and a 
scale between 0-4 is used to score each item. The assessment takes approximately 30 minutes to 
administer.  
Comparing the MDS-UPDRS to the UPDRS 
The MDS is an updated and psychometrically superior version of the UPDRS that tends to focus 
on the impact rather than the presence of symptoms. There are 9 new items in the MDS-UPDRS 
including fatigue, anxious mood, urinary problems, constipation, dopamine dysregulation 
syndrome, participating in hobbies, toe tapping, getting in and out of bed, and freezing. The 
MDS-UPDRS measures lightheadedness using a 0-4 rating scale as opposed to the original 
UPDRS that measured lightheadedness as either present or absent. The MDS-UPDRS also 
measures nighttime sleep problems and daytime sleepiness and the yes/no sleep disturbances 
option is replaced from the original UPDRS. The “Complexity of Motor Fluctuations” question 
in the MDS-UPDRS merges the three yes/no questions related to unpredictable, predictable, and 
sudden OFF period from the UPDRS. 
Importance of Using a Diagnosis-Specific Assessment 
Parkinson’s disease is generally treated as a secondary condition at Cottesmore. It is possible that 
patients with Parkinson’s disease as a primary diagnosis are not referred to Cottesmore to receive 
occupational therapy services because a case has not been made as to how occupational 
therapists can directly or even dramatically improve the lives of persons with the disease. All 
occupational therapists hold the responsibility of marketing the profession to clients, payers, 
administrators, and other vested individuals and groups. By taking the time to administer the 
MDS-UPDRS to clients with Parkinson’s disease, your team could gather persuasive data 
demonstrating improvement in Parkinson’s-related symptoms as they interfere with functional 
activities. In doing so, you could more directly demonstrate the profession’s worth and make a 
case for treating Parkinson’s disease as a primary diagnosis at Cottesmore.   
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How to Obtain the MDS-UPDRS 
1. Complete the Permissions Request Form: 
https://mds.movementdisorders.org/publications/rating_scales/request_form.php 
2. Print the instructions and scoring sheet: 
http://www.movementdisorders.org/MDS-Files1/PDFs/MDS-
UPDRS_English_FINAL.pdf 
Training (Recommended) 
Movement Disorder Society members: FREE 
Health professional, (non-physician/non-member): $250 
Movement Disorder Society Membership 
$100/$175* annual fee 
*Includes print subscription 
 
Psychometric Data Overview 
 
Psychometric Property Definition Data 
Internal Consistency  Measures whether several 
items that intend to measure 
the same general construct 
yield similar scores. 
Part I: Adequate (α = 0.79) 
Part II: Excellent (α = 0.90) 
Part III: Excellent (α = 
0.93) 
Part IV: Adequate (α = 
0.79) 
Concurrent Validity How closely the outcomes of 
one measure are similar to the 
outcomes of another measure. 
Part I: Excellent (r = 0.76) 
Part II: Excellent (r = 0.92) 
Part III: Excellent (r = 0.96) 
Part IV: Excellent (r = 0.89) 
Floor/Ceiling Effects When either really low or high 
scores are more common 
between individuals because 
the scale doesn’t distinguish 
differences at the extreme 
ends. 
Part I: Adequate (lowest 
0.1%/highest 0.8%) 
Part II: Adequate (lowest 
0.1%/highest 0.7%) 
Part III: Adequate (lowest 
0.1%/highest 0.2%) 
Part IV: Poor (floor effect 
but no ceiling effect) 
 
Psychometric data on the MDS-UPDRS is still limited. Construct validity, content validity, 
test-retest reliability, minimally clinically important difference, minimal detectable change, 
responsiveness, and standard error of the measurement have not been established.  
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Appendix D 
Items and costs associated with creating a CAHAI administration manual 
 
KIT ASSEMBLY FOR THE CAHAI-9 
Included below are a list of the items needed to administer the 9-item version of the Chedoke 
Arm and Hand Activity Inventory.  This list assumes that you buy every item new, but it is likely 
your clinic already has some of these items available for use.  Because the test was developed in 
Canada, many of the measurements are in metric.  When possible, American measurements have 
also been provided.  A complete list of resources is available at www.cahai.ca. 
 
Test item Details Estimated cost 
Dycem 7.5” mat or similar $14 
200g jar of coffee Twist-off lid, roughly 7-8oz  $6 to $12 
Push button telephone  $15 to $20 
12”/30cm ruler  $1 
8.5” x 11” paper  $7 per ream (500 
sheets) 
Pencil Will need sharpening and 
replacing 
$2 per dozen 
2.3L plastic pitcher with lid 2.25 quarts $10 
250mL plastic cup Roughly 8oz $10 per dozen 
Washcloth  $2 
Wash basin (24.5 cm. in diameter, 
height 8 cm.) 
9.5” diameter by 3” high, 
roughly 4 qt capacity 
$8 to $12 
Pull on vest with 5 buttons (one 
side male & one side female) 
See pattern in manual $5 (1 yard of fabric 
45” wide) 
Bath towel (65cm X 100cm)  $5 
75 ml toothpaste with screw lid, 
>50% full 
Roughly 2.5 ounces, will need to 
be replaced periodically 
$1 to $5 
Toothbrush  $1 
Dinner plate (Melamine or heavy 
plastic, 25 cm. in diameter) 
Roughly 10” $5 
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Medium resistance putty  $10 for 6 oz 
Knife and fork Consider Goodwill or similar $2 
Built up handles the length of the 
utensil handle 
 $15 to $20 for 
trimmable or pack of 4 
10 gallon storage bin  $20 
 
Total cost of assembling kit from scratch: about $152 
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Appendix E 
Follow-up survey for clinicians regarding implementation of the CAHAI 
 
Survey:  
1. On a scale of 1-10, how informative was the in-service?  
 
1    2    3    4    5    6    7    8    9    10 
(Not informative)                        (Extremely informative) 
 
Comments: 
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________ 
 
2. How useful was our research to your current practice in this setting? 
 
1    2    3    4    5    6    7    8    9    10 
(Not useful)                            (Extremely Useful) 
 
Comments:  
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________ 
 
3. Do you have any further questions about either the Chedoke or Movement Disorder Society’s 
Unified Parkinson’s Disease Rating Scale? 
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________ 
 
4. How likely are you and your team to adopt use of the Chedoke (CAHAI-9)?  
 
1    2    3    4    5    6    7    8    9    10 
 
(Not likely)                            (Extremely likely) 
 
5. How likely are you and your team to adopt use of the Movement Disorder Society’s Unified 
Parkinson’s Disease Rating Scale (MDS-UPDRS)?  
 
1    2    3    4    5    6    7    8    9    10 
 
(Not likely)                            (Extremely likely) 
 
6. Is there anything that we could do to make implementation of either assessment in your clinic 
easier or more practical?  
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____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________ 
 
7. What potential research interests or questions do you have for future UPS students? 
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________ 
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Permission for Scholarly Use of Thesis 
To properly administer the Research Repository and preserve the contents for future use, the University of 
Puget Sound requires certain permissions from the author(s) or copyright owner. By accepting this license, I 
still retain copyright to my work. I do not give up the right to submit the work to publishers or other 
repositories. By accepting this license, I grant to the University of Puget Sound the non-exclusive right to 
reproduce, translate (as defined below), and/or distribute my submission (including the abstract) worldwide, 
in any format or medium for non-commercial, academic purposes only. The University of Puget Sound will 
clearly identify my name(s) as the author(s) or owner(s) of the submission, including a statement of my 
copyright, and will not make any alteration, other than as allowed by this license, to my submission. I agree 
that the University of Puget Sound may, without changing the content, translate the submission to any 
medium or format and keep more than one copy for the purposes of security, back up and preservation. I 
also agree that authorized readers of my work have the right to use it for non-commercial, academic 
purposes as defined by the "fair use" doctrine of U.S. copyright law, so long as all attributions and 
copyright statements are retained. If the submission contains material for which I do not hold copyright and 
that exceeds fair use, I represent that I have obtained the unrestricted permission of the copyright owner to 
grant the University of Puget Sound the rights required by this license, and that such third-party owned 
material is clearly identified and acknowledged within the text or content of the submission. I further 
understand that, if I submit my project for publication and the publisher requires the transfer of copyright 
privileges, the University of Puget Sound will relinquish copyright, and remove the project from its website 
if required by the publisher. 
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